US20110166565A1 - Method of delivering energy to a lung airway using markers - Google Patents

Method of delivering energy to a lung airway using markers Download PDF

Info

Publication number
US20110166565A1
US20110166565A1 US13/050,833 US201113050833A US2011166565A1 US 20110166565 A1 US20110166565 A1 US 20110166565A1 US 201113050833 A US201113050833 A US 201113050833A US 2011166565 A1 US2011166565 A1 US 2011166565A1
Authority
US
United States
Prior art keywords
energy delivery
tissue
treatment
delivery device
markers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/050,833
Inventor
William J. Wizeman
Timothy R. Dalbec
Noah WEBSTER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asthmatx Inc
Original Assignee
Asthmatx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asthmatx Inc filed Critical Asthmatx Inc
Priority to US13/050,833 priority Critical patent/US20110166565A1/en
Assigned to ASTHMATX, INC. reassignment ASTHMATX, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DALBEC, TIMOTHY R., WEBSTER, NOAH, WIZEMAN, WILLIAM J.
Publication of US20110166565A1 publication Critical patent/US20110166565A1/en
Priority to US14/572,979 priority patent/US20150105775A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B18/1492Probes or electrodes therefor having a flexible, catheter-like structure, e.g. for heart ablation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00214Expandable means emitting energy, e.g. by elements carried thereon
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00214Expandable means emitting energy, e.g. by elements carried thereon
    • A61B2018/00267Expandable means emitting energy, e.g. by elements carried thereon having a basket shaped structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00541Lung or bronchi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3937Visible markers

Definitions

  • Asthma is a disease in which bronchoconstriction, excessive mucus production, and inflammation and swelling of airways occur. This causes widespread variable airflow obstruction which makes it difficult for an asthma sufferer to breathe. Asthma is a chronic disorder, primarily characterized by persistent airway inflammation. Asthma is further characterized by acute episodes of additional airway narrowing via contraction of hyper-responsive airway smooth muscle.
  • Asthma is traditionally managed pharmacologically by: (1) long term control through use of anti-inflammatories and long-acting bronchodilators and (2) short term management of acute exacerbations through use of short-acting bronchodilators. Both of these approaches require repeated and regular use of prescribed drugs, which often present difficulties in patient compliance. High doses of corticosteroid anti-inflammatory drugs can have serious side effects that require careful management. In addition, some patients are resistant to steroid treatment. The difficulty of avoiding stimulus that triggers asthma is also a common barrier to successful asthma management. As such, current management techniques are neither completely successful nor free from side effects.
  • RF radio frequency
  • FIG. 1 illustrates a bronchial tree 90 .
  • devices treating areas of the lungs desirably have a construction that enables navigation through the tortuous passages.
  • the various bronchioles 92 decrease in size and have many branching segments 96 as they extend into the right and left bronchi 94 .
  • an efficient treatment utilizes devices that are able to treat airways of varying sizes as well as function properly when repeatedly deployed after navigating through the tortuous anatomy.
  • the treatment devices In addition to considerations of navigation and site access, there exists the matter of device orientation at the treatment site.
  • the treatment devices generally make contact or are placed in close proximity to the target tissue.
  • visibility of the energy delivery element, particularly depth perception, within the lung airways may be relatively limited as viewed from an imaging lens of an access device, such as a bronchoscope or endoscope. Limited visibility combined with a variety of other factors, including airway movement due to patient breathing, coughing, and/or wheezing (tidal motion) as well as movement of the access device, may make it difficult to ensure desired axial treatment of the lung airways with the energy delivery device.
  • a relatively long region of tissue is to be treated (e.g., longer than a length of the energy delivery element)
  • difficulty in ascertaining the amount of tissue being treated may result in over-treatment of the same region or non-treatment of the target region.
  • portions of the target tissue may be over-treated or skipped entirely. Additionally, such conditions may result in slower procedures that increase total procedure time and patient discomfort.
  • a treatment device may utilize an elongate sheath or shaft having a plurality of markers, rings, bands, or other visual indicators along an outer surface thereof so as to facilitate guidance of the device to effectively and efficiently treat the tissue according to a predetermined axial treatment.
  • the predetermined axial treatment may be contiguous (adjacent), overlapping, intermittently spaced apart (gapping), or a combination thereof as determined by the marker spacing, and as desired.
  • the visual indicators may also serve as a mechanism for measuring a depth of the treatment device, the tissue length, and/or treatment length, as further described below.
  • an energy delivery device such as an RF electrode basket may be advanced within a working channel of an access device, such as a bronchoscope or endoscope, until a final proximal marker, e.g., a fourth mark, is extended outside the access device, such that the electrode basket, or at least a proximal insulation thereof, and the markers are visible via an imaging lens in the access device.
  • the electrode basket may be deployed into contact against the tissue to be treated and then activated.
  • the treatment device may then be pulled proximally until the next adjacent mark, e.g., a third mark, is reached. This process of activation and pulling proximally may be repeated until a last mark is reached providing for a contiguous and/or continuous axial treatment length of the tissue.
  • the treatment device which may be used in a body conduit, cavity, passageway, or lumen, such as a lung airway, may generally comprise an elongate body, an energy delivery element, and one or more visual indicators.
  • the elongate body comprises a proximal portion with a proximal end and a distal portion with a distal end.
  • the energy delivery element may be disposed at the distal end of the elongate body.
  • the one or more visual indicators may be disposed on the distal portion of the elongate body.
  • the visual indicators are separated by a predetermined spacing distance so as to provide the desired predetermined axial treatment in the body conduit or cavity.
  • the treatment device may comprise a radio frequency energy delivery device for use in a lung airway so as to treat asthma.
  • the device comprises an elongate body having a proximal portion with a proximal end and a distal portion with a distal end.
  • a RF electrode is disposed at the distal end of the elongate body.
  • a plurality of visual indicators are disposed on the distal portion of the elongate body, wherein the visual indicators are separated by a predetermined spacing distance so as to provide a predetermined axial treatment in a lung airway so as to treat asthma.
  • one method for using the treatment device to deliver energy may generally comprise positioning the access device having a visualization element within a lung airway so as to access airways that are typically 3 mm (or smaller) to 10 mm (or larger) in diameter, as can be properly viewed with direct real-time visualization.
  • the access device may then be stabilized or anchored.
  • the energy delivery device is advanced within the access device so that at least one visual indicator disposed on a distal portion of the energy delivery device and proximal an energy element delivery element disposed on a distal end of the energy delivery device is positioned outside the access device as verified with the visualization element.
  • the visual indicators in turn will provide the desired predetermined axial treatment in the lung airway with the energy delivery element relative to the access device.
  • FIG. 1 is an illustration of the airways within a human lung.
  • FIG. 2 illustrates a schematic view of a treatment system for delivering energy to tissue utilizing an expandable electrode basket.
  • FIG. 3A illustrates a side view of the treatment device of FIG. 2 extending distally from a bronchoscope, wherein the device has an active distal end for treating tissue using energy delivery.
  • FIG. 3B illustrates a variation of a treatment device comprising an expandable body, such as a balloon, having one or more electrodes disposed along its surface.
  • FIG. 4 illustrates an exemplary schematic view of an expandable electrode basket projecting distally from an elongate sheath having one or more markers delineated along its length and a representative image on a monitor corresponding to an image as viewed from the bronchoscope, wherein the spacing distance between each adjacent marker corresponds to a length of the electrodes located on the treatment device.
  • FIG. 5 illustrates the energy delivery device of FIG. 4 advanced into a bronchial airway and positioned for treatment upon the tissue.
  • FIGS. 6A and 6B illustrates the treatment device advanced distally within an airway lumen for treating the tissue and the corresponding image from a bronchoscope on a monitor showing the markers along the sheath.
  • FIGS. 7A and 7B illustrate the treatment device pulled proximally along the tissue by a length corresponding to a length between markers along the sheath such that the treatment device is aligned to an adjacent region of tissue to be treated.
  • FIGS. 8A and 8B illustrate the treatment device pulled further proximally along the tissue by a length corresponding to a length between markers along the sheath such that the treatment device is aligned to another adjacent region of tissue to be treated.
  • FIG. 9A illustrates a variation of the sheath utilizing dashed markers.
  • FIG. 9B illustrates another variation of the sheath utilizing non-uniform markers.
  • FIG. 9C illustrates another variation of the sheath utilizing markers which have a length between adjacent markers which is less than a length of the electrodes on the treatment device such that overlapping regions of tissue may be treated.
  • FIG. 9D illustrates yet another variation of the sheath utilizing markers having graduated measurements therealong to provide a visual indication of tissue or treatment length and/or electrode basket depth.
  • FIG. 9E illustrates yet another variation of the sheath utilizing markers having alternative colors, such as a green marker to indicate treatment device deployment or a red marker to indicate a maximum length of sheath extension.
  • FIG. 9F illustrates still another variation of the sheath utilizing markers which have a length between adjacent markers which is greater than a length of the electrodes on the treatment device such that intermittent regions of tissue may be treated.
  • the devices and methods described herein are not limited to use in the bronchial passageways. Instead, such devices and methods may have applicability in various parts of the body, such as the upper respiratory tract, trachea, esophagus, urethra, ureter, digestive tract, cardiovascular system, circulatory system, arthroscopic, brain, liver, etc. Moreover, the present invention may be used in various procedures where the benefits of the device are desired.
  • the treatment device may utilize an elongate body, such as tubular sheath, shaft, or catheter, having a plurality of markers, rings, bands, or other visual indicators (e.g., circular or otherwise) along an outer surface thereof.
  • the plurality of visual indicators facilitate guidance of the device to effectively and efficiently treat the tissue according to a predetermined axial treatment.
  • the predetermined axial treatment may be contiguous, overlapping, or intermittently spaced apart treatment of the lung airway walls with the energy delivery element(s).
  • the plurality of visual indicators may also serve as a mechanism to measure a depth of the device, tissue length, airway segment length, and/or treatment length.
  • the treatment device such as an RF electrode basket assembly
  • an access device such as a bronchoscope
  • the electrode basket assembly may be deployed against the tissue to be treated and activated.
  • the treatment device may then be pulled proximally relative to the access device until the next adjacent marker is reached.
  • the treatment device may then be activated to treat the portion of tissue adjacent to the previously treated portion without overlap (i.e., over-treatment of the same region) or separation (i.e., non-treatment of target tissue) between the adjacent portions of treated tissue.
  • This process of activation and pulling proximally may be repeated until the last mark is reached providing for a continuous axial treatment where the target tissue regions are neither over-treated nor skipped.
  • FIG. 2 a schematic diagram of one example of a treatment system 10 for delivering therapeutic energy to tissue of a patient is illustrated.
  • the system 10 comprises a power supply having an energy generator 12 , a controller 14 coupled to the energy generator 12 , and a user interface surface 16 in communication with the controller 14 .
  • the system 10 further includes an energy delivery device 20 , a return electrode 40 (if the system 10 employs a mono-polar RF configuration), and foot actuation pedal(s) 42 .
  • the above depictions are for illustrative purposes only and do not necessarily reflect the actual shape, size, or dimensions of the system 10 or device 20 . This applies to all depictions hereinafter.
  • the system 10 depicted in FIG. 2 shows the user interface portion 16 having one or more connections 36 , 44 , 46 for the device 20 , the return electrode 40 (optional), and the actuation pedal(s) 42 (optional) respectively.
  • the user interface 16 may also include visual prompts 48 , 50 , 52 , 54 for user feedback regarding setup or operation of the system 10 .
  • the user interface 16 may also employ graphical representations of components of the system 10 , audio tone generators, as well as other features to assist the user with system operation.
  • the controller 14 may be configured to deliver RF energy in either a mono-polar or bi-polar configuration.
  • the controller 14 may include a processor 38 that is generally configured to accept information from the system and system components, and process the information according to various algorithms to produce control signals for controlling the energy generator 12 .
  • the processor 38 may also accept information from the system 10 and system components, process the information according to various algorithms and produce information signals that may be directed to the visual indicators, digital display or audio tone generator of the user interface in order to inform the user of the system status, component status, procedure status or any other useful information that is being monitored by the system.
  • the processor 38 of the controller 14 may be a digital IC processor, analog processor, or any other suitable logic or control system that carries out the control algorithms.
  • the device 20 of the present invention may be used with a variety of systems 10 , having the same or different components as described in FIG. 2 .
  • the device 20 is described with reference to RF energy delivery systems 10
  • variations of the device and system may include light energy sources, laser systems, resistive heating systems, infrared heating elements, microwave energy systems, focused ultrasound, cryo-ablation, radiation, electrical stimulation, or any other energy delivery system or configuration.
  • the energy delivery device 20 may include a flexible tubular sheath 22 , an elongate shaft 24 (in this example, the shaft 24 extends out from the distal end of the sheath 22 ), and a handle or other optional operator interface 26 secured to a proximal end of the sheath 22 .
  • the distal portion of the device 20 includes an energy transfer element 28 for applying energy to the tissue of interest.
  • the energy transfer element 28 such as an expandable electrode basket, may be advanced into and through the patient body in an atraumatic low profile configuration. Upon reaching the designed tissue region to be treated, the energy transfer element 28 may be expanded or reconfigured into a treatment configuration which facilitates contact of the element 28 against the tissue to be treated. In one example, the energy transfer element 28 may be reconfigured via a pull wire 21 routed proximally through elongate shaft 24 and/or flexible sheath 22 and affixed to a handle 26 and actuated with a slide mechanism 34 .
  • the device 20 may includes a connector 30 common to such energy delivery devices.
  • the connector 30 may be integral to the end of a cable 32 coupled to the handle 26 or the connector 30 may be fitted to receive a separate cable 32 .
  • the device 20 is configured for attachment to the power supply via some type of connector or adaptor plug 30 .
  • the elongate shaft 24 and/or flexible sheath 22 may also be configured and sized to permit passage through a working channel of a commercially available bronchoscope or endoscope.
  • the device 20 may also be advanced into a body conduit or cavity with or without a steerable catheter, in a minimally invasive procedure, in an open surgical procedure, or with or without the guidance of various vision or imaging systems.
  • the devices 20 of the present invention will have a sufficient length and/or diameter and/or flexibility to access the tissue targeted for treatment.
  • treating airways as small as 3 mm in diameter may utilize the flexible sheath 22 and/or elongate shaft 24 which is sufficiently long and sized in diameter to reach deep into the lungs to treat the airways.
  • the device shaft 24 and/or sheath 22 will have a length in range from about 0.5 feet to about 8.0 feet and an expanded basket diameter 28 in a range from about 1 mm to about 25 mm, more preferably from about 3 mm to about 10 mm.
  • this example is merely illustrative and is not limiting in dimension or flexibility.
  • an example of an energy transfer device 28 is illustrated as an expandable electrode basket.
  • the device 28 has one or more legs 60 configured in the form of a basket 62 converging to an atraumatic common distal tip 68 .
  • the basket 62 may reconfigure from an atraumatic low profile shape to an expanded or deployed configuration to facilitate contact against the tissue walls of a body conduit, cavity, passageway, or lumen, such as a lung airway wall. Examples of such devices are described in greater detail in commonly assigned U.S. Publication No. 2003/0233099, which is incorporated herein by reference.
  • the one or more legs 60 may be configured into the basket shape 62 such that the legs 60 may expand radially during operation to a working diameter as described above that will achieve contact between the legs 60 having active electrode regions 64 and the airway walls.
  • the legs 60 may also include temperature sensors for tissue temperature feedback to the controller 14 . In this configuration, four legs 60 are shown, however any number of legs 60 may be utilized to form the basket 62 (e.g., 2, 3, 4, 5, 6, 7, 8, 9, 10, etc.).
  • a pull wire 66 may extend through a lumen of the elongate shaft body 24 , to which the basket 62 may be directly mounted. Pull wire 66 may be utilized to deliver energy to the active electrodes 64 and/or assist basket 62 in expanding into its deployed treatment configuration.
  • the treatment device 62 may optionally be delivered to a treatment site directly through the elongate delivery sheath or sleeve body 22 .
  • pull wire 66 may be omitted entirely in which case basket 62 may be expanded or deployed by utilizing one or more legs 60 which are fabricated as elastic, super-elastic, or shape memory alloys (e.g., nickel-titanium alloys) which may self-expand from a compressed configuration when removed from the elongate sheath 22 .
  • basket 62 may expand upon activation by the user or it may automatically expand when advanced out of a restraining sheath 22 or when the sheath 22 is withdrawn proximally from the basket 62 .
  • the energy transfer device 28 is shown in association with a bronchoscope access device 70 .
  • the elongate shaft 24 and flexible sheath 22 are received within a working channel 72 of the bronchoscope 70 .
  • the energy transfer device 28 may be utilized along with an imaging lumen 76 and/or light optical fibers 74 of the bronchoscope 70 .
  • the imaging lumen 76 may utilize visualization elements, such as CCD imaging or a camera lens.
  • the bronchoscope 70 may additionally comprise an aspiration lumen (not shown).
  • the active member 80 is configured as a body 82 having a set diameter and length.
  • One or more electrodes 84 are shown secured to the body 82 through holes 86 or adhesives or other attachment mechanisms.
  • the electrodes 84 may be oriented axially relative to the body 82 to optimize contact along the tissue walls during treatment.
  • the diameter of active member 80 is set to correspond to that desired for treating a given body lumen or passageway, such as lung airway.
  • body 82 may be configured as an inflatable balloon member, an expandable scaffold member, and the like, where the electrodes 84 will move outward upon body 82 expansion.
  • Energy delivery devices 28 , 80 of wire frames and/or basket configurations will generally have its members (e.g., electrodes) symmetrically deployed. This shape may be round, rounded, or polygonal in cross section. These and other configurations, including asymmetrical active member configurations, are described in detail in U.S. patent application Ser. Nos. 11/255,796, filed Oct. 21, 2005, entitled IMPROVED ENERGY DELIVERY DEVICES AND METHODS and 11/420,438, filed. May 25, 2006, entitled MEDICAL DEVICE WITH PROCEDURE IMPROVEMENT FEATURES, each of which is incorporated herein by reference.
  • FIG. 4 one variation of an exemplary treatment device is shown which facilitates guidance of the expandable electrode basket 62 so as to effectively and efficiently treat tissue as desired, particularly relatively long portions of tissue (e.g., regions of tissue longer than a length of the electrode 64 ).
  • the basket 62 is disposed at the distal end of the elongate sheath 22 which in turn is shown projecting distally outward from the bronchoscope 70 .
  • One or more visual indicators 100 are disposed along a length of the elongate sheath 22 (or shaft 24 ), preferably on a distal portion of the sheath 22 and proximal to the basket 62 .
  • Visual indicators 100 may generally comprise one or more markers, rings, bands, and the like.
  • a first marker 102 may be positioned proximally of basket 62
  • a second marker 104 may be positioned proximally of first marker 102
  • a third marker 106 may be positioned proximally of second marker 104
  • a fourth marker 108 may be positioned proximally of third marker 106 .
  • at least two circular bands or rings may be utilized and in other variations, four circular bands or rings may be utilized. It will be appreciated that any number, type, and/or combination of markers, rings or bands may be utilized in the present invention (e.g., 2, 3, 4, 5, 6, 7, 8, 9, 10, etc.).
  • Each marker 102 , 104 , 106 , 108 may be uniformly spaced apart from one another with each spacing matching the length of the active electrodes 64 of basket 62 .
  • each spacing between markers 102 , 104 , 106 , 108 may be set to correspond to a length of a active electrode 64 located centrally between proximal and distal insulation regions 61 , 63 of the basket leg 60 .
  • active electrodes 64 having a length of 5 mm along basket 62 may provide for a length of 5 mm between markers 102 , 104 , 106 , 108 .
  • the active electrode length 64 and corresponding marker spacing of 5 mm is illustrative and other lengths fewer than 5 mm or greater than 5 mm may also be utilized as desired.
  • the predetermined spacing distance may range anywhere from about 3 mm to about 30 mm, more preferably in a range from about 5 mm to about 15 mm, depending on the active electrode length, basket leg length, electrode array length parallel to a longitudinal axis of the airway lumen, treatment temperature, time, power, current, voltage, and/or energy settings, and/or polarity configuration.
  • the spacing between these markers 102 , 104 , 106 , 108 may each correspond to a length LE of the active electrodes 64 on basket 62 .
  • a first marker distance LS 1 between first marker 102 and second marker 104 may correspond in length to the length LE of active electrodes 64 on basket 62 .
  • a second marker distance LS 2 between second marker 104 and third marker 106 may each correspond in length to the length LE of active electrodes 64 on basket 62 .
  • four markers are illustrated in this example, fewer than four or more than four markers, as desired, may be utilized along the length of elongate sheath 22 in alternative variations.
  • Bronchoscope 70 may be electrically coupled 110 to a monitor 112 and/or processor configured to display images 114 received from imaging lumen 76 .
  • the displayed image corresponds to an image as viewed from the perspective of lumen 76 showing basket 62 projected from the elongate sheath 22 .
  • the visual markings 100 positioned along the sheath 22 .
  • the embodiment of FIG. 4 allows for the amount of tissue being treated by the basket 62 to be easily ascertained with reference to the visual markers 100 .
  • markers 100 improve visibility and/or navigation of locating and placing the treatment electrodes 64 so as to reliably and uniformly apply predetermined axial treatments (e.g., continuous activation treatments). This in turn may reduce physician effort or fatigue (e.g., less surgical technique sensitive), total treatment procedure time, and/or patient discomfort and improve procedure efficacy.
  • the basket 62 and elongate sheath 22 may be deployed from bronchoscope 70 and positioned distally of bronchoscope 70 along the tissue wall of a bifurcated airway 96 .
  • basket 62 may be deployed from bronchoscope 70 and advanced distally relative to bronchoscope working channel 72 , as shown in FIG. 6A , while visualizing the passage of markers 102 , 104 , 106 , 108 in monitor 112 directly in real-time, as illustrated in FIG. 6B .
  • basket 62 With basket 62 positioned, it may be expanded into contact against the surrounding tissue wall 96 and the active electrodes 64 may be activated to heat the airway tissue 120 along a treatment length LE 3 .
  • the treated tissue length LE 3 extending between tissue borders 122 , 124 , may correspond in length to third marker spacing distance LS 3 on elongate sheath 22 .
  • basket 62 may be retracted and withdrawn proximally relative to bronchoscope 70 while visualizing on monitor 112 by one marker length until the fourth marker 108 is no longer visible and third marker 106 is verified as visible in the monitor 112 , as shown in FIG. 7B .
  • Moving elongate sheath 22 by such a distance also translates basket 62 proximally by one marker length LS 3 and correspondingly translates the active electrodes 64 to an adjacent tissue region proximal to the previously treated tissue length LE 3 .
  • basket 62 may then again be actuated so as to deploy against the airway wall 96 and activated to heat the airway tissue 121 along a treatment length LE 2 which borders treated tissue length LE 3 contiguously without overlapping or leaving any gap between the two treated tissue lengths, as shown in FIG. 7A .
  • basket 62 may once again be retracted and withdrawn proximally relative to bronchoscope 70 by another marker length such that third marker 106 is no longer visible and second marker 104 is verified as visible on the monitor 112 , as shown in FIG. 8B . Accordingly, basket 62 is translated proximally by a corresponding distance along the tissue such that the active electrodes 64 are aligned between tissue borders 126 and 128 . The basket 62 may then be activated to treat the tissue region 123 along tissue length LE 1 which borders treated tissue length LE 2 , as illustrated in FIG. 8A .
  • This process of deploying, activating, retracting, and pulling proximally may be repeated, as desired, until first marker 102 is reached or by pulling the bronchoscope 70 proximally with respect to the sheath markers 100 and following the above steps relative to the stationary bronchoscope 70 .
  • longer portions of the tissue may be treated as desired.
  • the resulting treated tissue may be thus formed into a contiguous length of treated tissue (e.g., LE 1 , LE 2 , LE 3 ) which avoids over-treating the tissue by avoiding overlapping regions and avoids the formation of gaps between adjacent tissue lengths.
  • the basket 62 may be withdrawn proximally into the bronchoscope working channel 72 for withdrawal from the patient or advancement into another region of tissue to be treated.
  • the tissue may be treated in increments of 5, 10, 15, 20 mm or more in a contiguous manner depending upon the desired length of tissue to be treated.
  • the predetermined axial treatment may comprise treatment of the lung airways for a length of at least 10 mm, preferably in a range from about 10 mm to about 75 mm, more preferably in a range from about 20 mm to about 30 mm.
  • elongate sheath 22 may be translated distally relative to bronchoscope 70 such that the initial treatment is initiated when first marker 102 is visualized. Accordingly, subsequent portions of tissue may be treated by advancing the basket 62 distally relative to bronchoscope 70 while viewing advancement of the markers on monitor 112 .
  • the elongate sheath 22 and basket 62 may be initially advanced distally until the first marker 102 , second marker 104 , or third marker 106 is exposed rather than being fully advanced until the fourth marker 108 is exposed. Thus, shorter portions of the tissue may be treated as desired.
  • markers 100 may be identical, it will be appreciated that they may also be varied in any number of configurations.
  • FIG. 9A illustrates one variation where the markers 130 , 132 , 134 , 136 may be dashed rather than solid.
  • FIG. 9B Another variation is shown in FIG. 9B where the markers may be non-uniform in width, or alternating in width.
  • markers 140 , 144 may have a first width while alternating markers 142 , 146 may have a second width larger than the first width.
  • markers 150 , 152 , 154 , 156 may be aligned to correspond to the active electrode length, as described above. Additional half markers 158 , 160 , 162 may be marked at, e.g., intermediate positions between markers 150 , 152 , 154 , 156 , to denote positions where portions of tissue may be treated by overlapping the treatment regions, as shown in FIG. 9C .
  • markers 170 , 172 , 174 , 176 may be graduated with length measurements, e.g., 5 mm, 10 mm, 15 mm, 20 mm, etc., much like an endoscope to facilitate measurement of basket 62 insertion depth or to facilitate measurement of the tissue region (e.g., length of the lung airway).
  • a portion of tissue or the depth in which the treatment device is advanced may be ascertained by directly visualizing the elongate sheath 22 extending from the stationary bronchoscope 70 .
  • any number of incremental values may be marked and delineated either in a corresponding or even non-corresponding manner with respect to the active electrodes, if so desired.
  • marker 180 may comprise a first color (e.g., green) to indicate that once marker 180 is visible, electrode basket 62 is sufficiently advanced relative to the bronchoscope 70 for expansion and/or activation.
  • Additional markers 182 , 184 may also comprise various colors as well while the proximal marker 186 may also be colored in yet another color (e.g., red) as a visual indication that the elongate sheath 22 should not be advanced any further distal into the airway lung.
  • markers 171 , 173 , 175 may have a length between adjacent markers which is greater than a length of the active electrodes 64 of the treatment device so that intermittent regions of tissue may be treated, as shown in FIG. 9F .
  • the sheath may have a second set of markers 177 , 179 , 181 , 183 that have a different spacing distance, e.g., set to the active electrode 64 length, so that a user may utilize a particular marker set based on a particular anatomy section to be treated.
  • each of the markers may be marked on the elongate sheath 22 in various increments and are not limited to just the length of the active electrodes 64 , as described above in detail. Moreover, additional markers may be utilized or as few as a single marker may be utilized depending upon the desired visual indications.
  • the markers may also serve as a safety feature to discourage the pre-mature deployment of the electrode basket 62 within the bronchoscope 70 .
  • the first proximal marker may serve this purpose so as to prevent against any electrical discharge from flowing proximally along the sheath 22 , shaft 24 and/or bronchoscope 70 , which could potentially result in injury or harm to the patient or user.
  • the final proximal marker which may be positioned along sheath 22 up to 75 mm or more, more preferably up to 50 mm or 30 mm, from the electrode basket 62 , may also serve as a visual safety feature to ensure against advancing the electrode basket 62 too deep into the patient body (i.e., beyond bronchoscopic vision), which in turn prevents against any patient harm, such as puncturing of the airway wall into the parenchyma, pneumothorax, pneumomediastinum, etc.
  • At least one of the markers may also be aligned with an anatomical landmark within the lung airway to provide not only for alignment of the device but also to facilitate measurement of the lung airway, if so desired.
  • a marker may be aligned with a particular airway bifurcation, colored tissue, cartilage ring, tissue nodule, and the like, so as to ensure against user disorientation due to tidal motion or movement of the access device.
  • the markers 102 further allow for user differentiation of the sheath 22 from the insulated electrodes 61 , 63 , particularly the proximal insulation regions of the basket legs 60 . This visualization is important to ensure proper deployment of the basket electrode 62 .
  • the plurality of visual indicators may be located on the device shaft, the energy delivery device may comprise a non-RF source, and/or the expandable energy device may comprise an inflatable balloon member.
  • the markers of the present invention may be positioned alternatively or additionally on a proximal portion of the sheath or shaft that extends at least partially outside the access device and patient.

Abstract

An energy delivery device for treating tissue regions in a body conduit, such as a lung airway, may utilize one or more markers, rings, bands, or other visual indicators along an outer surface of the device body. The one or more visual indicators facilitate guidance of the device to effectively and efficiently treat the tissue according to a predetermined axial treatment as well as measure extension of a distal portion of the device, tissue length, and/or treatment length. The predetermined axial treatment may be contiguous, overlapping, or intermittently spaced apart as determined by the marker spacing distance.

Description

    BACKGROUND OF THE INVENTION
  • Asthma is a disease in which bronchoconstriction, excessive mucus production, and inflammation and swelling of airways occur. This causes widespread variable airflow obstruction which makes it difficult for an asthma sufferer to breathe. Asthma is a chronic disorder, primarily characterized by persistent airway inflammation. Asthma is further characterized by acute episodes of additional airway narrowing via contraction of hyper-responsive airway smooth muscle.
  • Asthma is traditionally managed pharmacologically by: (1) long term control through use of anti-inflammatories and long-acting bronchodilators and (2) short term management of acute exacerbations through use of short-acting bronchodilators. Both of these approaches require repeated and regular use of prescribed drugs, which often present difficulties in patient compliance. High doses of corticosteroid anti-inflammatory drugs can have serious side effects that require careful management. In addition, some patients are resistant to steroid treatment. The difficulty of avoiding stimulus that triggers asthma is also a common barrier to successful asthma management. As such, current management techniques are neither completely successful nor free from side effects.
  • Presently, a new treatment for asthma is showing promise. This treatment comprises the application of energy to the airway tissue. This treatment is described in more detail in commonly assigned U.S. Pat. Nos. 6,411,852; 6,634,363; 7,027,869; 7,104,987 and U.S. Publication No. 2005/0010270, each of which is incorporated herein by reference.
  • The application of energy to airway tissue, when performed via insertion of a treatment device into the bronchial passageways, requires navigation through tortuous anatomy as well as the ability to treat a variety of sizes of bronchial passageways. As discussed in the above referenced patents and applications, use of a radio frequency (RF) energy delivery device provides one mechanism for treating tissue within the bronchial passageways.
  • FIG. 1 illustrates a bronchial tree 90. As noted herein, devices treating areas of the lungs desirably have a construction that enables navigation through the tortuous passages. As shown, the various bronchioles 92 decrease in size and have many branching segments 96 as they extend into the right and left bronchi 94. Accordingly, an efficient treatment utilizes devices that are able to treat airways of varying sizes as well as function properly when repeatedly deployed after navigating through the tortuous anatomy.
  • In addition to considerations of navigation and site access, there exists the matter of device orientation at the treatment site. The treatment devices generally make contact or are placed in close proximity to the target tissue. However, in utilizing the treatment devices in a patient, visibility of the energy delivery element, particularly depth perception, within the lung airways may be relatively limited as viewed from an imaging lens of an access device, such as a bronchoscope or endoscope. Limited visibility combined with a variety of other factors, including airway movement due to patient breathing, coughing, and/or wheezing (tidal motion) as well as movement of the access device, may make it difficult to ensure desired axial treatment of the lung airways with the energy delivery device.
  • For example, in procedures where a relatively long region of tissue is to be treated (e.g., longer than a length of the energy delivery element), difficulty in ascertaining the amount of tissue being treated may result in over-treatment of the same region or non-treatment of the target region. In particular, as the energy delivery element is translated from a first region to a second region and so on, portions of the target tissue may be over-treated or skipped entirely. Additionally, such conditions may result in slower procedures that increase total procedure time and patient discomfort.
  • In view of the above, methods and devices are desired for treating tortuous anatomy such as the bronchial passages which enable a user to effectively and efficiently treat tissue and relocate an energy delivery device along one or more portions of the tissue.
  • SUMMARY OF THE INVENTION
  • In treating tissue regions, such as within the lungs, a treatment device may utilize an elongate sheath or shaft having a plurality of markers, rings, bands, or other visual indicators along an outer surface thereof so as to facilitate guidance of the device to effectively and efficiently treat the tissue according to a predetermined axial treatment. The predetermined axial treatment may be contiguous (adjacent), overlapping, intermittently spaced apart (gapping), or a combination thereof as determined by the marker spacing, and as desired. The visual indicators may also serve as a mechanism for measuring a depth of the treatment device, the tissue length, and/or treatment length, as further described below.
  • In one aspect of the present invention, an energy delivery device such as an RF electrode basket may be advanced within a working channel of an access device, such as a bronchoscope or endoscope, until a final proximal marker, e.g., a fourth mark, is extended outside the access device, such that the electrode basket, or at least a proximal insulation thereof, and the markers are visible via an imaging lens in the access device. The electrode basket may be deployed into contact against the tissue to be treated and then activated. The treatment device may then be pulled proximally until the next adjacent mark, e.g., a third mark, is reached. This process of activation and pulling proximally may be repeated until a last mark is reached providing for a contiguous and/or continuous axial treatment length of the tissue.
  • In another aspect of the present invention, the treatment device which may be used in a body conduit, cavity, passageway, or lumen, such as a lung airway, may generally comprise an elongate body, an energy delivery element, and one or more visual indicators. The elongate body comprises a proximal portion with a proximal end and a distal portion with a distal end. The energy delivery element may be disposed at the distal end of the elongate body. The one or more visual indicators may be disposed on the distal portion of the elongate body. Significantly, the visual indicators are separated by a predetermined spacing distance so as to provide the desired predetermined axial treatment in the body conduit or cavity.
  • In yet another aspect of the prevent invention, the treatment device may comprise a radio frequency energy delivery device for use in a lung airway so as to treat asthma. The device comprises an elongate body having a proximal portion with a proximal end and a distal portion with a distal end. A RF electrode is disposed at the distal end of the elongate body. A plurality of visual indicators are disposed on the distal portion of the elongate body, wherein the visual indicators are separated by a predetermined spacing distance so as to provide a predetermined axial treatment in a lung airway so as to treat asthma.
  • In a further aspect of the present invention, one method for using the treatment device to deliver energy may generally comprise positioning the access device having a visualization element within a lung airway so as to access airways that are typically 3 mm (or smaller) to 10 mm (or larger) in diameter, as can be properly viewed with direct real-time visualization. The access device may then be stabilized or anchored. The energy delivery device is advanced within the access device so that at least one visual indicator disposed on a distal portion of the energy delivery device and proximal an energy element delivery element disposed on a distal end of the energy delivery device is positioned outside the access device as verified with the visualization element. The visual indicators in turn will provide the desired predetermined axial treatment in the lung airway with the energy delivery element relative to the access device.
  • A further understanding of the nature and advantages of the present invention will become apparent by reference to the remaining portions of the specification and drawings.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The following drawings should be read with reference to the detailed description. Like numbers in different drawings refer to like elements. The drawings, which are not necessarily to scale, illustratively depict embodiments of the present invention and are not intended to limit the scope of the invention.
  • FIG. 1 is an illustration of the airways within a human lung.
  • FIG. 2 illustrates a schematic view of a treatment system for delivering energy to tissue utilizing an expandable electrode basket.
  • FIG. 3A illustrates a side view of the treatment device of FIG. 2 extending distally from a bronchoscope, wherein the device has an active distal end for treating tissue using energy delivery.
  • FIG. 3B illustrates a variation of a treatment device comprising an expandable body, such as a balloon, having one or more electrodes disposed along its surface.
  • FIG. 4 illustrates an exemplary schematic view of an expandable electrode basket projecting distally from an elongate sheath having one or more markers delineated along its length and a representative image on a monitor corresponding to an image as viewed from the bronchoscope, wherein the spacing distance between each adjacent marker corresponds to a length of the electrodes located on the treatment device.
  • FIG. 5 illustrates the energy delivery device of FIG. 4 advanced into a bronchial airway and positioned for treatment upon the tissue.
  • FIGS. 6A and 6B illustrates the treatment device advanced distally within an airway lumen for treating the tissue and the corresponding image from a bronchoscope on a monitor showing the markers along the sheath.
  • FIGS. 7A and 7B illustrate the treatment device pulled proximally along the tissue by a length corresponding to a length between markers along the sheath such that the treatment device is aligned to an adjacent region of tissue to be treated.
  • FIGS. 8A and 8B illustrate the treatment device pulled further proximally along the tissue by a length corresponding to a length between markers along the sheath such that the treatment device is aligned to another adjacent region of tissue to be treated.
  • FIG. 9A illustrates a variation of the sheath utilizing dashed markers.
  • FIG. 9B illustrates another variation of the sheath utilizing non-uniform markers.
  • FIG. 9C illustrates another variation of the sheath utilizing markers which have a length between adjacent markers which is less than a length of the electrodes on the treatment device such that overlapping regions of tissue may be treated.
  • FIG. 9D illustrates yet another variation of the sheath utilizing markers having graduated measurements therealong to provide a visual indication of tissue or treatment length and/or electrode basket depth.
  • FIG. 9E illustrates yet another variation of the sheath utilizing markers having alternative colors, such as a green marker to indicate treatment device deployment or a red marker to indicate a maximum length of sheath extension.
  • FIG. 9F illustrates still another variation of the sheath utilizing markers which have a length between adjacent markers which is greater than a length of the electrodes on the treatment device such that intermittent regions of tissue may be treated.
  • DETAILED DESCRIPTION OF THE INVENTION
  • It will be appreciated that the examples below discuss uses in the airways of the lungs. However, unless specifically noted, the devices and methods described herein are not limited to use in the bronchial passageways. Instead, such devices and methods may have applicability in various parts of the body, such as the upper respiratory tract, trachea, esophagus, urethra, ureter, digestive tract, cardiovascular system, circulatory system, arthroscopic, brain, liver, etc. Moreover, the present invention may be used in various procedures where the benefits of the device are desired.
  • Generally, in treating tissue regions within the lungs, the treatment device may utilize an elongate body, such as tubular sheath, shaft, or catheter, having a plurality of markers, rings, bands, or other visual indicators (e.g., circular or otherwise) along an outer surface thereof. The plurality of visual indicators facilitate guidance of the device to effectively and efficiently treat the tissue according to a predetermined axial treatment. The predetermined axial treatment may be contiguous, overlapping, or intermittently spaced apart treatment of the lung airway walls with the energy delivery element(s). The plurality of visual indicators may also serve as a mechanism to measure a depth of the device, tissue length, airway segment length, and/or treatment length.
  • In one example of operation, the treatment device, such as an RF electrode basket assembly, may be advanced within a working channel of an access device, such as a bronchoscope, until a final proximal marker is extended distally from the access device while under direct real-time visualization. With the treatment device and the markers visible through the access device, the electrode basket assembly may be deployed against the tissue to be treated and activated. The treatment device may then be pulled proximally relative to the access device until the next adjacent marker is reached. The treatment device may then be activated to treat the portion of tissue adjacent to the previously treated portion without overlap (i.e., over-treatment of the same region) or separation (i.e., non-treatment of target tissue) between the adjacent portions of treated tissue. This process of activation and pulling proximally may be repeated until the last mark is reached providing for a continuous axial treatment where the target tissue regions are neither over-treated nor skipped.
  • Referring now to FIG. 2, a schematic diagram of one example of a treatment system 10 for delivering therapeutic energy to tissue of a patient is illustrated. The system 10 comprises a power supply having an energy generator 12, a controller 14 coupled to the energy generator 12, and a user interface surface 16 in communication with the controller 14. The system 10 further includes an energy delivery device 20, a return electrode 40 (if the system 10 employs a mono-polar RF configuration), and foot actuation pedal(s) 42. It will be appreciated that the above depictions are for illustrative purposes only and do not necessarily reflect the actual shape, size, or dimensions of the system 10 or device 20. This applies to all depictions hereinafter.
  • The system 10 depicted in FIG. 2 shows the user interface portion 16 having one or more connections 36, 44, 46 for the device 20, the return electrode 40 (optional), and the actuation pedal(s) 42 (optional) respectively. The user interface 16 may also include visual prompts 48, 50, 52, 54 for user feedback regarding setup or operation of the system 10. The user interface 16 may also employ graphical representations of components of the system 10, audio tone generators, as well as other features to assist the user with system operation.
  • The controller 14 may be configured to deliver RF energy in either a mono-polar or bi-polar configuration. In many variations of the system 10, the controller 14 may include a processor 38 that is generally configured to accept information from the system and system components, and process the information according to various algorithms to produce control signals for controlling the energy generator 12. The processor 38 may also accept information from the system 10 and system components, process the information according to various algorithms and produce information signals that may be directed to the visual indicators, digital display or audio tone generator of the user interface in order to inform the user of the system status, component status, procedure status or any other useful information that is being monitored by the system. The processor 38 of the controller 14 may be a digital IC processor, analog processor, or any other suitable logic or control system that carries out the control algorithms.
  • Detailed descriptions on the processor 38, user interface 16, and safety algorithms that are useful for the treatment of asthma as discussed above may be found in commonly assigned U.S. patent application Ser. No. 11/408,688, filed Apr. 21, 2006, entitled CONTROL METHODS AND DEVICES FOR ENERGY DELIVERY, which is incorporated herein by reference.
  • It is understood that the device 20 of the present invention may be used with a variety of systems 10, having the same or different components as described in FIG. 2. For example, although the device 20 is described with reference to RF energy delivery systems 10, variations of the device and system may include light energy sources, laser systems, resistive heating systems, infrared heating elements, microwave energy systems, focused ultrasound, cryo-ablation, radiation, electrical stimulation, or any other energy delivery system or configuration.
  • The energy delivery device 20 may include a flexible tubular sheath 22, an elongate shaft 24 (in this example, the shaft 24 extends out from the distal end of the sheath 22), and a handle or other optional operator interface 26 secured to a proximal end of the sheath 22. The distal portion of the device 20 includes an energy transfer element 28 for applying energy to the tissue of interest. The energy transfer element 28, such as an expandable electrode basket, may be advanced into and through the patient body in an atraumatic low profile configuration. Upon reaching the designed tissue region to be treated, the energy transfer element 28 may be expanded or reconfigured into a treatment configuration which facilitates contact of the element 28 against the tissue to be treated. In one example, the energy transfer element 28 may be reconfigured via a pull wire 21 routed proximally through elongate shaft 24 and/or flexible sheath 22 and affixed to a handle 26 and actuated with a slide mechanism 34.
  • Additionally, the device 20 may includes a connector 30 common to such energy delivery devices. The connector 30 may be integral to the end of a cable 32 coupled to the handle 26 or the connector 30 may be fitted to receive a separate cable 32. In any case, the device 20 is configured for attachment to the power supply via some type of connector or adaptor plug 30. The elongate shaft 24 and/or flexible sheath 22 may also be configured and sized to permit passage through a working channel of a commercially available bronchoscope or endoscope. However, the device 20 may also be advanced into a body conduit or cavity with or without a steerable catheter, in a minimally invasive procedure, in an open surgical procedure, or with or without the guidance of various vision or imaging systems.
  • The devices 20 of the present invention will have a sufficient length and/or diameter and/or flexibility to access the tissue targeted for treatment. For example, treating airways as small as 3 mm in diameter may utilize the flexible sheath 22 and/or elongate shaft 24 which is sufficiently long and sized in diameter to reach deep into the lungs to treat the airways. Generally the device shaft 24 and/or sheath 22 will have a length in range from about 0.5 feet to about 8.0 feet and an expanded basket diameter 28 in a range from about 1 mm to about 25 mm, more preferably from about 3 mm to about 10 mm. However, it is noted that this example is merely illustrative and is not limiting in dimension or flexibility.
  • Referring now to FIG. 3A, an example of an energy transfer device 28 is illustrated as an expandable electrode basket. The device 28 has one or more legs 60 configured in the form of a basket 62 converging to an atraumatic common distal tip 68. The basket 62 may reconfigure from an atraumatic low profile shape to an expanded or deployed configuration to facilitate contact against the tissue walls of a body conduit, cavity, passageway, or lumen, such as a lung airway wall. Examples of such devices are described in greater detail in commonly assigned U.S. Publication No. 2003/0233099, which is incorporated herein by reference.
  • The one or more legs 60 may be configured into the basket shape 62 such that the legs 60 may expand radially during operation to a working diameter as described above that will achieve contact between the legs 60 having active electrode regions 64 and the airway walls. The legs 60 may also include temperature sensors for tissue temperature feedback to the controller 14. In this configuration, four legs 60 are shown, however any number of legs 60 may be utilized to form the basket 62 (e.g., 2, 3, 4, 5, 6, 7, 8, 9, 10, etc.).
  • As illustrated in FIG. 3A, a pull wire 66 may extend through a lumen of the elongate shaft body 24, to which the basket 62 may be directly mounted. Pull wire 66 may be utilized to deliver energy to the active electrodes 64 and/or assist basket 62 in expanding into its deployed treatment configuration. The treatment device 62 may optionally be delivered to a treatment site directly through the elongate delivery sheath or sleeve body 22. In still other embodiments, pull wire 66 may be omitted entirely in which case basket 62 may be expanded or deployed by utilizing one or more legs 60 which are fabricated as elastic, super-elastic, or shape memory alloys (e.g., nickel-titanium alloys) which may self-expand from a compressed configuration when removed from the elongate sheath 22. In summary, basket 62 may expand upon activation by the user or it may automatically expand when advanced out of a restraining sheath 22 or when the sheath 22 is withdrawn proximally from the basket 62.
  • The energy transfer device 28 is shown in association with a bronchoscope access device 70. The elongate shaft 24 and flexible sheath 22 are received within a working channel 72 of the bronchoscope 70. Accordingly, the energy transfer device 28 may be utilized along with an imaging lumen 76 and/or light optical fibers 74 of the bronchoscope 70. The imaging lumen 76 may utilize visualization elements, such as CCD imaging or a camera lens. The bronchoscope 70 may additionally comprise an aspiration lumen (not shown).
  • Referring now to FIG. 3B, an alternative configuration of the energy transfer device 80 is illustrated. The active member 80 is configured as a body 82 having a set diameter and length. One or more electrodes 84 are shown secured to the body 82 through holes 86 or adhesives or other attachment mechanisms. The electrodes 84 may be oriented axially relative to the body 82 to optimize contact along the tissue walls during treatment. The diameter of active member 80 is set to correspond to that desired for treating a given body lumen or passageway, such as lung airway. Accordingly, body 82 may be configured as an inflatable balloon member, an expandable scaffold member, and the like, where the electrodes 84 will move outward upon body 82 expansion.
  • Energy delivery devices 28, 80 of wire frames and/or basket configurations will generally have its members (e.g., electrodes) symmetrically deployed. This shape may be round, rounded, or polygonal in cross section. These and other configurations, including asymmetrical active member configurations, are described in detail in U.S. patent application Ser. Nos. 11/255,796, filed Oct. 21, 2005, entitled IMPROVED ENERGY DELIVERY DEVICES AND METHODS and 11/420,438, filed. May 25, 2006, entitled MEDICAL DEVICE WITH PROCEDURE IMPROVEMENT FEATURES, each of which is incorporated herein by reference.
  • Referring now to FIG. 4, one variation of an exemplary treatment device is shown which facilitates guidance of the expandable electrode basket 62 so as to effectively and efficiently treat tissue as desired, particularly relatively long portions of tissue (e.g., regions of tissue longer than a length of the electrode 64). In this embodiment, the basket 62 is disposed at the distal end of the elongate sheath 22 which in turn is shown projecting distally outward from the bronchoscope 70. One or more visual indicators 100 are disposed along a length of the elongate sheath 22 (or shaft 24), preferably on a distal portion of the sheath 22 and proximal to the basket 62. Visual indicators 100 may generally comprise one or more markers, rings, bands, and the like. For example, a first marker 102 may be positioned proximally of basket 62, a second marker 104 may be positioned proximally of first marker 102, a third marker 106 may be positioned proximally of second marker 104, and a fourth marker 108 may be positioned proximally of third marker 106. In another variation, at least two circular bands or rings may be utilized and in other variations, four circular bands or rings may be utilized. It will be appreciated that any number, type, and/or combination of markers, rings or bands may be utilized in the present invention (e.g., 2, 3, 4, 5, 6, 7, 8, 9, 10, etc.).
  • Each marker 102, 104, 106, 108 may be uniformly spaced apart from one another with each spacing matching the length of the active electrodes 64 of basket 62. Thus, each spacing between markers 102, 104, 106, 108 may be set to correspond to a length of a active electrode 64 located centrally between proximal and distal insulation regions 61, 63 of the basket leg 60. For instance, active electrodes 64 having a length of 5 mm along basket 62 may provide for a length of 5 mm between markers 102, 104, 106, 108. It will be appreciated that the active electrode length 64 and corresponding marker spacing of 5 mm is illustrative and other lengths fewer than 5 mm or greater than 5 mm may also be utilized as desired. For example, the predetermined spacing distance may range anywhere from about 3 mm to about 30 mm, more preferably in a range from about 5 mm to about 15 mm, depending on the active electrode length, basket leg length, electrode array length parallel to a longitudinal axis of the airway lumen, treatment temperature, time, power, current, voltage, and/or energy settings, and/or polarity configuration.
  • As mentioned above, in one variation the spacing between these markers 102, 104, 106, 108 may each correspond to a length LE of the active electrodes 64 on basket 62. For instance, a first marker distance LS1 between first marker 102 and second marker 104, a second marker distance LS2 between second marker 104 and third marker 106, and a third marker distance LS3 between third marker 106 and fourth marker 108 may each correspond in length to the length LE of active electrodes 64 on basket 62. Moreover, although four markers are illustrated in this example, fewer than four or more than four markers, as desired, may be utilized along the length of elongate sheath 22 in alternative variations.
  • Bronchoscope 70 may be electrically coupled 110 to a monitor 112 and/or processor configured to display images 114 received from imaging lumen 76. As represented on monitor 112, the displayed image corresponds to an image as viewed from the perspective of lumen 76 showing basket 62 projected from the elongate sheath 22. Also illustrated are the visual markings 100 positioned along the sheath 22.
  • Advantageously, the embodiment of FIG. 4 allows for the amount of tissue being treated by the basket 62 to be easily ascertained with reference to the visual markers 100. In particular, markers 100 improve visibility and/or navigation of locating and placing the treatment electrodes 64 so as to reliably and uniformly apply predetermined axial treatments (e.g., continuous activation treatments). This in turn may reduce physician effort or fatigue (e.g., less surgical technique sensitive), total treatment procedure time, and/or patient discomfort and improve procedure efficacy.
  • Referring now to FIGS. 5 through 8B, the basket 62 and elongate sheath 22 may be deployed from bronchoscope 70 and positioned distally of bronchoscope 70 along the tissue wall of a bifurcated airway 96. In one example of use, basket 62 may be deployed from bronchoscope 70 and advanced distally relative to bronchoscope working channel 72, as shown in FIG. 6A, while visualizing the passage of markers 102, 104, 106, 108 in monitor 112 directly in real-time, as illustrated in FIG. 6B. With basket 62 positioned, it may be expanded into contact against the surrounding tissue wall 96 and the active electrodes 64 may be activated to heat the airway tissue 120 along a treatment length LE3. The treated tissue length LE3, extending between tissue borders 122, 124, may correspond in length to third marker spacing distance LS3 on elongate sheath 22.
  • Once the treatment is completed along tissue length LE3, basket 62 may be retracted and withdrawn proximally relative to bronchoscope 70 while visualizing on monitor 112 by one marker length until the fourth marker 108 is no longer visible and third marker 106 is verified as visible in the monitor 112, as shown in FIG. 7B. Moving elongate sheath 22 by such a distance also translates basket 62 proximally by one marker length LS3 and correspondingly translates the active electrodes 64 to an adjacent tissue region proximal to the previously treated tissue length LE3. Once desirably positioned, basket 62 may then again be actuated so as to deploy against the airway wall 96 and activated to heat the airway tissue 121 along a treatment length LE2 which borders treated tissue length LE3 contiguously without overlapping or leaving any gap between the two treated tissue lengths, as shown in FIG. 7A.
  • Once the tissue along tissue length LE2 has been treated, basket 62 may once again be retracted and withdrawn proximally relative to bronchoscope 70 by another marker length such that third marker 106 is no longer visible and second marker 104 is verified as visible on the monitor 112, as shown in FIG. 8B. Accordingly, basket 62 is translated proximally by a corresponding distance along the tissue such that the active electrodes 64 are aligned between tissue borders 126 and 128. The basket 62 may then be activated to treat the tissue region 123 along tissue length LE1 which borders treated tissue length LE2, as illustrated in FIG. 8A. This process of deploying, activating, retracting, and pulling proximally may be repeated, as desired, until first marker 102 is reached or by pulling the bronchoscope 70 proximally with respect to the sheath markers 100 and following the above steps relative to the stationary bronchoscope 70. Thus, longer portions of the tissue may be treated as desired.
  • The resulting treated tissue may be thus formed into a contiguous length of treated tissue (e.g., LE1, LE2, LE3) which avoids over-treating the tissue by avoiding overlapping regions and avoids the formation of gaps between adjacent tissue lengths. Once the treatment is completed, the basket 62 may be withdrawn proximally into the bronchoscope working channel 72 for withdrawal from the patient or advancement into another region of tissue to be treated. Thus, if the length of the active electrode 64 is 5 mm and the corresponding marker lengths LS1, LS2, LS3 are each 5 mm in length, the tissue may be treated in increments of 5, 10, 15, 20 mm or more in a contiguous manner depending upon the desired length of tissue to be treated. The predetermined axial treatment (e.g., LE1, LE2, LE3) may comprise treatment of the lung airways for a length of at least 10 mm, preferably in a range from about 10 mm to about 75 mm, more preferably in a range from about 20 mm to about 30 mm.
  • It will be appreciated that there are several ways to use the device of the present invention, and as such is not limited by the above example. In an alternative method of use, elongate sheath 22 may be translated distally relative to bronchoscope 70 such that the initial treatment is initiated when first marker 102 is visualized. Accordingly, subsequent portions of tissue may be treated by advancing the basket 62 distally relative to bronchoscope 70 while viewing advancement of the markers on monitor 112. In yet another variation, the elongate sheath 22 and basket 62 may be initially advanced distally until the first marker 102, second marker 104, or third marker 106 is exposed rather than being fully advanced until the fourth marker 108 is exposed. Thus, shorter portions of the tissue may be treated as desired.
  • Referring now to FIGS. 9A through 9F, although markers 100 may be identical, it will be appreciated that they may also be varied in any number of configurations. For example, FIG. 9A illustrates one variation where the markers 130, 132, 134, 136 may be dashed rather than solid. Another variation is shown in FIG. 9B where the markers may be non-uniform in width, or alternating in width. For instance, markers 140, 144 may have a first width while alternating markers 142, 146 may have a second width larger than the first width.
  • In yet another variation, the markers 150, 152, 154, 156 may be aligned to correspond to the active electrode length, as described above. Additional half markers 158, 160, 162 may be marked at, e.g., intermediate positions between markers 150, 152, 154, 156, to denote positions where portions of tissue may be treated by overlapping the treatment regions, as shown in FIG. 9C.
  • Another variation is illustrated in FIG. 9D where markers 170, 172, 174, 176 may be graduated with length measurements, e.g., 5 mm, 10 mm, 15 mm, 20 mm, etc., much like an endoscope to facilitate measurement of basket 62 insertion depth or to facilitate measurement of the tissue region (e.g., length of the lung airway). In this manner, a portion of tissue or the depth in which the treatment device is advanced may be ascertained by directly visualizing the elongate sheath 22 extending from the stationary bronchoscope 70. Although the measurement values are illustrated in 5 mm increments corresponding to the length of the active electrode 64 on the electrode basket 62, any number of incremental values may be marked and delineated either in a corresponding or even non-corresponding manner with respect to the active electrodes, if so desired.
  • Referring now to FIG. 9E, an elongate sheath 22 having markers which are in various colors to denote particular features associated with that particular marking is illustrated. Although the markers may be colored in the same color (e.g., black), various colors may be utilized, particularly to indicate predetermined device states. For example, marker 180 may comprise a first color (e.g., green) to indicate that once marker 180 is visible, electrode basket 62 is sufficiently advanced relative to the bronchoscope 70 for expansion and/or activation. Additional markers 182, 184 may also comprise various colors as well while the proximal marker 186 may also be colored in yet another color (e.g., red) as a visual indication that the elongate sheath 22 should not be advanced any further distal into the airway lung.
  • In yet another variation, markers 171, 173, 175 (with graduations 7 mm, 14 mm, 21 mm) may have a length between adjacent markers which is greater than a length of the active electrodes 64 of the treatment device so that intermittent regions of tissue may be treated, as shown in FIG. 9F. Still further, the sheath may have a second set of markers 177, 179, 181, 183 that have a different spacing distance, e.g., set to the active electrode 64 length, so that a user may utilize a particular marker set based on a particular anatomy section to be treated.
  • In these and other variations described herein, each of the markers may be marked on the elongate sheath 22 in various increments and are not limited to just the length of the active electrodes 64, as described above in detail. Moreover, additional markers may be utilized or as few as a single marker may be utilized depending upon the desired visual indications.
  • The markers may also serve as a safety feature to discourage the pre-mature deployment of the electrode basket 62 within the bronchoscope 70. For example, the first proximal marker may serve this purpose so as to prevent against any electrical discharge from flowing proximally along the sheath 22, shaft 24 and/or bronchoscope 70, which could potentially result in injury or harm to the patient or user. Additionally, the final proximal marker, which may be positioned along sheath 22 up to 75 mm or more, more preferably up to 50 mm or 30 mm, from the electrode basket 62, may also serve as a visual safety feature to ensure against advancing the electrode basket 62 too deep into the patient body (i.e., beyond bronchoscopic vision), which in turn prevents against any patient harm, such as puncturing of the airway wall into the parenchyma, pneumothorax, pneumomediastinum, etc.
  • In yet another alternative, at least one of the markers may also be aligned with an anatomical landmark within the lung airway to provide not only for alignment of the device but also to facilitate measurement of the lung airway, if so desired. For example, a marker may be aligned with a particular airway bifurcation, colored tissue, cartilage ring, tissue nodule, and the like, so as to ensure against user disorientation due to tidal motion or movement of the access device.
  • Referring back to FIG. 8B, it will be further appreciated that the markers 102 further allow for user differentiation of the sheath 22 from the insulated electrodes 61, 63, particularly the proximal insulation regions of the basket legs 60. This visualization is important to ensure proper deployment of the basket electrode 62.
  • Although certain exemplary embodiments and methods have been described in some detail, for clarity of understanding and by way of example, it will be apparent from the foregoing disclosure to those skilled in the art that variations, modifications, changes, and adaptations of such embodiments and methods may be made without departing from the true spirit and scope of the invention. For example, the plurality of visual indicators may be located on the device shaft, the energy delivery device may comprise a non-RF source, and/or the expandable energy device may comprise an inflatable balloon member. Still further, the markers of the present invention may be positioned alternatively or additionally on a proximal portion of the sheath or shaft that extends at least partially outside the access device and patient. Proximal makers may also facilitate quicker and more confident introduction of the shaft into the access device by indicating a measurement of the shaft within the access device. Reference to a singular element, includes the possibility that there are plural of the same elements present. More specifically, as used herein and in the appended claims, the singular forms “a,” “an,” “said,” and “the” include plural referents unless the context clearly dictates otherwise. Therefore, the above description should not be taken as limiting the scope of the invention which is defined by the appended claims.

Claims (13)

1. An energy delivery device for use in a body conduit or cavity, the device comprising:
an elongate body having a proximal portion with a proximal end and a distal portion with a distal end;
an energy delivery element disposed at the distal end of the elongate body; and
a plurality of visual indicators disposed on the distal portion of the elongate body, wherein the visual indicators are separated by a predetermined spacing distance so as to provide a predetermined axial treatment in a body conduit or cavity.
2. The energy delivery device of claim 1, wherein the predetermined axial treatment comprises contiguous, overlapping, intermittent, or combination treatment thereof of the body conduit or cavity with the energy delivery element.
3. The energy delivery device of claim 1, wherein the energy delivery element comprises an electrode, wherein the predetermined spacing distance comprises an active electrode length.
4. The energy delivery device of claim 1, wherein the predetermined spacing comprises a distance in a range from about 3 mm to about 30 mm.
5. The energy delivery device of claim 1, wherein the predetermined spacing comprises a distance of about 5 mm.
6. The energy delivery device of claim 1, wherein the plurality of visual indicators comprise two circular bands or rings.
7. The energy delivery device of claim 1, wherein the plurality of visual indicators comprise four circular bands or rings.
8. The energy delivery device of claim 1, wherein the plurality of visual indicators comprise two identical markers.
9. The energy delivery device of claim 1, wherein the plurality of visual indicators comprise two markers having different colors or non-uniform configurations.
10. The energy delivery device of claim 1, wherein the elongate body comprises a tubular sheath or shaft.
11. The energy delivery device of claim 1, further comprising a proximal marker disposed on the proximal portion of the elongate body.
12. A radio frequency energy delivery device for use in a lung airway so as to treat asthma, the device comprising:
an elongate body having a proximal portion with a proximal end and a distal portion with a distal end;
a radio frequency electrode disposed at the distal end of the elongate body; and
a plurality of visual indicators disposed on the distal portion of the elongate body, wherein the visual indicators are separated by a predetermined spacing distance so as to provide a predetermined axial treatment in a lung airway so as to treat asthma.
13-27. (canceled)
US13/050,833 2006-10-20 2011-03-17 Method of delivering energy to a lung airway using markers Abandoned US20110166565A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US13/050,833 US20110166565A1 (en) 2006-10-20 2011-03-17 Method of delivering energy to a lung airway using markers
US14/572,979 US20150105775A1 (en) 2006-10-20 2014-12-17 Electrode markers and methods of use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/551,639 US7931647B2 (en) 2006-10-20 2006-10-20 Method of delivering energy to a lung airway using markers
US13/050,833 US20110166565A1 (en) 2006-10-20 2011-03-17 Method of delivering energy to a lung airway using markers

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US11/551,639 Division US7931647B2 (en) 2006-10-20 2006-10-20 Method of delivering energy to a lung airway using markers

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US14/572,979 Continuation US20150105775A1 (en) 2006-10-20 2014-12-17 Electrode markers and methods of use

Publications (1)

Publication Number Publication Date
US20110166565A1 true US20110166565A1 (en) 2011-07-07

Family

ID=39318966

Family Applications (3)

Application Number Title Priority Date Filing Date
US11/551,639 Active 2029-08-17 US7931647B2 (en) 2006-10-20 2006-10-20 Method of delivering energy to a lung airway using markers
US13/050,833 Abandoned US20110166565A1 (en) 2006-10-20 2011-03-17 Method of delivering energy to a lung airway using markers
US14/572,979 Abandoned US20150105775A1 (en) 2006-10-20 2014-12-17 Electrode markers and methods of use

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US11/551,639 Active 2029-08-17 US7931647B2 (en) 2006-10-20 2006-10-20 Method of delivering energy to a lung airway using markers

Family Applications After (1)

Application Number Title Priority Date Filing Date
US14/572,979 Abandoned US20150105775A1 (en) 2006-10-20 2014-12-17 Electrode markers and methods of use

Country Status (7)

Country Link
US (3) US7931647B2 (en)
EP (1) EP2083734B1 (en)
JP (1) JP5422389B2 (en)
AU (1) AU2007309319B2 (en)
CA (1) CA2667009C (en)
ES (1) ES2398980T3 (en)
WO (1) WO2008051706A2 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060225742A1 (en) * 2003-05-13 2006-10-12 The Foundry, Inc. Apparatus for treating asthma using neurotoxin
US8226638B2 (en) 2008-05-09 2012-07-24 Innovative Pulmonary Solutions, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8483831B1 (en) 2008-02-15 2013-07-09 Holaira, Inc. System and method for bronchial dilation
US8740895B2 (en) 2009-10-27 2014-06-03 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US8911439B2 (en) 2009-11-11 2014-12-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
US9149328B2 (en) 2009-11-11 2015-10-06 Holaira, Inc. Systems, apparatuses, and methods for treating tissue and controlling stenosis
EP2959855A1 (en) * 2014-06-25 2015-12-30 Günter Farin Electrosurgical resection loop with an exposed part and with a part provided with an insulation
US9398933B2 (en) 2012-12-27 2016-07-26 Holaira, Inc. Methods for improving drug efficacy including a combination of drug administration and nerve modulation
US9867978B1 (en) 2016-09-16 2018-01-16 Precision Neurotechnologies Llc Conformal electrode arrays for electrophysiologic recording and neural stimulation within the cerebral ventricles
US10702337B2 (en) 2016-06-27 2020-07-07 Galary, Inc. Methods, apparatuses, and systems for the treatment of pulmonary disorders

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7992572B2 (en) 1998-06-10 2011-08-09 Asthmatx, Inc. Methods of evaluating individuals having reversible obstructive pulmonary disease
US6488673B1 (en) * 1997-04-07 2002-12-03 Broncus Technologies, Inc. Method of increasing gas exchange of a lung
US7027869B2 (en) 1998-01-07 2006-04-11 Asthmatx, Inc. Method for treating an asthma attack
US6634363B1 (en) * 1997-04-07 2003-10-21 Broncus Technologies, Inc. Methods of treating lungs having reversible obstructive pulmonary disease
US7921855B2 (en) 1998-01-07 2011-04-12 Asthmatx, Inc. Method for treating an asthma attack
US8181656B2 (en) 1998-06-10 2012-05-22 Asthmatx, Inc. Methods for treating airways
US7198635B2 (en) 2000-10-17 2007-04-03 Asthmatx, Inc. Modification of airways by application of energy
US8251070B2 (en) 2000-03-27 2012-08-28 Asthmatx, Inc. Methods for treating airways
US7104987B2 (en) 2000-10-17 2006-09-12 Asthmatx, Inc. Control system and process for application of energy to airway walls and other mediums
US7949407B2 (en) 2004-11-05 2011-05-24 Asthmatx, Inc. Energy delivery devices and methods
WO2006052940A2 (en) 2004-11-05 2006-05-18 Asthmatx, Inc. Medical device with procedure improvement features
US20070093802A1 (en) 2005-10-21 2007-04-26 Danek Christopher J Energy delivery devices and methods
US8721634B2 (en) * 2005-07-21 2014-05-13 Covidien Lp Apparatus and method for ensuring thermal treatment of a hollow anatomical structure
US7993323B2 (en) 2006-11-13 2011-08-09 Uptake Medical Corp. High pressure and high temperature vapor catheters and systems
US8235983B2 (en) 2007-07-12 2012-08-07 Asthmatx, Inc. Systems and methods for delivering energy to passageways in a patient
WO2009015278A1 (en) * 2007-07-24 2009-01-29 Asthmatx, Inc. System and method for controlling power based on impedance detection, such as controlling power to tissue treatment devices
US20090043301A1 (en) * 2007-08-09 2009-02-12 Asthmatx, Inc. Monopolar energy delivery devices and methods for controlling current density in tissue
US8322335B2 (en) 2007-10-22 2012-12-04 Uptake Medical Corp. Determining patient-specific vapor treatment and delivery parameters
JP5865702B2 (en) * 2008-04-03 2016-02-17 メドトロニック,インク.Medtronic,Inc. System and method for hyperthermia treatment
US20100160906A1 (en) * 2008-12-23 2010-06-24 Asthmatx, Inc. Expandable energy delivery devices having flexible conductive elements and associated systems and methods
WO2011127216A2 (en) * 2010-04-06 2011-10-13 Innovative Pulmonary Solutions, Inc. System and method for pulmonary treatment
EP2563256B1 (en) 2010-04-26 2019-08-28 Medtronic Holding Company Sàrl Electrosurgical device
WO2013052501A1 (en) 2011-10-05 2013-04-11 Innovative Pulmonary Solutions, Inc. Apparatus for injuring nerve tissue
CN107080561B (en) 2011-12-09 2020-09-11 麦特文申公司 Apparatus, system and method for neuromodulation
WO2013184319A1 (en) 2012-06-04 2013-12-12 Boston Scientific Scimed, Inc. Systems and methods for treating tissue of a passageway within a body
EP2877113B1 (en) 2012-07-24 2018-07-25 Boston Scientific Scimed, Inc. Electrodes for tissue treatment
WO2014071372A1 (en) 2012-11-05 2014-05-08 Boston Scientific Scimed, Inc. Devices for delivering energy to body lumens
CA2896787A1 (en) * 2013-02-05 2014-08-14 Handok Inc. Catheter for denervation
WO2014164847A1 (en) * 2013-03-12 2014-10-09 Boston Scientific Scimed, Inc. Retrieval device and related methods of use
EP2967397B1 (en) 2013-03-15 2023-07-12 Medtronic Holding Company Sàrl Electrosurgical mapping tools
US9814618B2 (en) 2013-06-06 2017-11-14 Boston Scientific Scimed, Inc. Devices for delivering energy and related methods of use
US9782211B2 (en) 2013-10-01 2017-10-10 Uptake Medical Technology Inc. Preferential volume reduction of diseased segments of a heterogeneous lobe
US10792490B2 (en) 2013-11-12 2020-10-06 Medtronic, Inc. Open channel implant tools and implant techniques utilizing such tools
US9610436B2 (en) * 2013-11-12 2017-04-04 Medtronic, Inc. Implant tools with attachment feature and multi-positional sheath and implant techniques utilizing such tools
JP5802869B1 (en) * 2014-01-23 2015-11-04 オリンパス株式会社 Surgical device
US10485604B2 (en) 2014-12-02 2019-11-26 Uptake Medical Technology Inc. Vapor treatment of lung nodules and tumors
US11083491B2 (en) 2014-12-09 2021-08-10 Medtronic, Inc. Extravascular implant tools utilizing a bore-in mechanism and implant techniques using such tools
US10349978B2 (en) 2014-12-18 2019-07-16 Medtronic, Inc. Open channel implant tool with additional lumen and implant techniques utilizing such tools
US10531906B2 (en) 2015-02-02 2020-01-14 Uptake Medical Technology Inc. Medical vapor generator
US10441339B2 (en) 2015-11-17 2019-10-15 Medtronic Holding Company Sárl Spinal tissue ablation apparatus, system, and method
US11129673B2 (en) 2017-05-05 2021-09-28 Uptake Medical Technology Inc. Extra-airway vapor ablation for treating airway constriction in patients with asthma and COPD
US11344364B2 (en) 2017-09-07 2022-05-31 Uptake Medical Technology Inc. Screening method for a target nerve to ablate for the treatment of inflammatory lung disease
CN109464186B (en) 2017-09-08 2023-12-22 泽丹医疗股份有限公司 Device and method for treating lung tumors
US11350988B2 (en) 2017-09-11 2022-06-07 Uptake Medical Technology Inc. Bronchoscopic multimodality lung tumor treatment
USD845467S1 (en) 2017-09-17 2019-04-09 Uptake Medical Technology Inc. Hand-piece for medical ablation catheter
US20190117971A1 (en) * 2017-10-23 2019-04-25 Cardiac Pacemakers, Inc. Volume-filling leads for treatment of cancer with electric fields
US11419658B2 (en) 2017-11-06 2022-08-23 Uptake Medical Technology Inc. Method for treating emphysema with condensable thermal vapor
US11490946B2 (en) 2017-12-13 2022-11-08 Uptake Medical Technology Inc. Vapor ablation handpiece
US11653927B2 (en) 2019-02-18 2023-05-23 Uptake Medical Technology Inc. Vapor ablation treatment of obstructive lung disease
CN113727753A (en) 2019-04-22 2021-11-30 波士顿科学国际有限公司 Electrical stimulation device for cancer treatment
CN110507413B (en) * 2019-09-16 2020-06-19 浙江大学 Microwave therapeutic instrument with controllable ablation effective hot area
US11883655B2 (en) 2020-02-24 2024-01-30 Boston Scientific Scimed, Inc. Systems and methods for treatment of pancreatic cancer

Citations (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2072346A (en) * 1934-10-04 1937-03-02 Ward R Smith Drainage tube
US3568659A (en) * 1968-09-24 1971-03-09 James N Karnegis Disposable percutaneous intracardiac pump and method of pumping blood
US4317458A (en) * 1979-04-26 1982-03-02 Kabushiki Kaisha Top Electrode apparatus for pacing
US4503855A (en) * 1981-12-31 1985-03-12 Harald Maslanka High frequency surgical snare electrode
US4565200A (en) * 1980-09-24 1986-01-21 Cosman Eric R Universal lesion and recording electrode system
US4567882A (en) * 1982-12-06 1986-02-04 Vanderbilt University Method for locating the illuminated tip of an endotracheal tube
US4643186A (en) * 1985-10-30 1987-02-17 Rca Corporation Percutaneous transluminal microwave catheter angioplasty
US4799479A (en) * 1984-10-24 1989-01-24 The Beth Israel Hospital Association Method and apparatus for angioplasty
US4802492A (en) * 1987-03-11 1989-02-07 National Jewish Center For Immunology And Respiratory Medicine Method for determining respiratory function
US5078716A (en) * 1990-05-11 1992-01-07 Doll Larry F Electrosurgical apparatus for resecting abnormal protruding growth
US5084044A (en) * 1989-07-14 1992-01-28 Ciron Corporation Apparatus for endometrial ablation and method of using same
US5096916A (en) * 1990-05-07 1992-03-17 Aegis Technology, Inc. Treatment of chronic obstructive pulmonary disease (copd) by inhalation of an imidazoline
US5100423A (en) * 1990-08-21 1992-03-31 Medical Engineering & Development Institute, Inc. Ablation catheter
US5100388A (en) * 1989-09-15 1992-03-31 Interventional Thermodynamics, Inc. Method and device for thermal ablation of hollow body organs
US5188602A (en) * 1990-07-12 1993-02-23 Interventional Thermodynamics, Inc. Method and device for delivering heat to hollow body organs
US5191883A (en) * 1988-10-28 1993-03-09 Prutech Research And Development Partnership Ii Device for heating tissue in a patient's body
US5281218A (en) * 1992-06-05 1994-01-25 Cardiac Pathways Corporation Catheter having needle electrode for radiofrequency ablation
US5292331A (en) * 1989-08-24 1994-03-08 Applied Vascular Engineering, Inc. Endovascular support device
US5293869A (en) * 1992-09-25 1994-03-15 Ep Technologies, Inc. Cardiac probe with dynamic support for maintaining constant surface contact during heart systole and diastole
US5383917A (en) * 1991-07-05 1995-01-24 Jawahar M. Desai Device and method for multi-phase radio-frequency ablation
US5394880A (en) * 1994-03-17 1995-03-07 Atlee, Iii; John L. Esophageal stethoscope
US5396887A (en) * 1993-09-23 1995-03-14 Cardiac Pathways Corporation Apparatus and method for detecting contact pressure
US5400783A (en) * 1993-10-12 1995-03-28 Cardiac Pathways Corporation Endocardial mapping apparatus with rotatable arm and method
US5496271A (en) * 1990-09-14 1996-03-05 American Medical Systems, Inc. Combined hyperthermia and dilation catheter
US5496311A (en) * 1988-10-28 1996-03-05 Boston Scientific Corporation Physiologic low stress angioplasty
US5500011A (en) * 1986-11-14 1996-03-19 Desai; Jawahar M. Catheter for mapping and ablation and method therefor
US5595183A (en) * 1995-02-17 1997-01-21 Ep Technologies, Inc. Systems and methods for examining heart tissue employing multiple electrode structures and roving electrodes
US5599345A (en) * 1993-11-08 1997-02-04 Zomed International, Inc. RF treatment apparatus
US5598848A (en) * 1994-03-31 1997-02-04 Ep Technologies, Inc. Systems and methods for positioning multiple electrode structures in electrical contact with the myocardium
US5601088A (en) * 1995-02-17 1997-02-11 Ep Technologies, Inc. Systems and methods for filtering artifacts from composite signals
US5605157A (en) * 1995-02-17 1997-02-25 Ep Technologies, Inc. Systems and methods for filtering signals derived from biological events
US5607462A (en) * 1993-09-24 1997-03-04 Cardiac Pathways Corporation Catheter assembly, catheter and multi-catheter introducer for use therewith
US5607419A (en) * 1995-04-24 1997-03-04 Angiomedics Ii Inc. Method and apparatus for treating vessel wall with UV radiation following angioplasty
US5707352A (en) * 1989-08-28 1998-01-13 Alliance Pharmaceutical Corp. Pulmonary delivery of therapeutic agent
US5720745A (en) * 1992-11-24 1998-02-24 Erbe Electromedizin Gmbh Electrosurgical unit and method for achieving coagulation of biological tissue
US5722401A (en) * 1994-10-19 1998-03-03 Cardiac Pathways Corporation Endocardial mapping and/or ablation catheter probe
US5722416A (en) * 1995-02-17 1998-03-03 Ep Technologies, Inc. Systems and methods for analyzing biopotential morphologies in heart tissue to locate potential ablation sites
US5722403A (en) * 1996-10-28 1998-03-03 Ep Technologies, Inc. Systems and methods using a porous electrode for ablating and visualizing interior tissue regions
US5725525A (en) * 1993-03-16 1998-03-10 Ep Technologies, Inc. Multiple electrode support structures with integral hub and spline elements
US5728094A (en) * 1996-02-23 1998-03-17 Somnus Medical Technologies, Inc. Method and apparatus for treatment of air way obstructions
US5730741A (en) * 1997-02-07 1998-03-24 Eclipse Surgical Technologies, Inc. Guided spiral catheter
US5730726A (en) * 1996-03-04 1998-03-24 Klingenstein; Ralph James Apparatus and method for removing fecal impaction
US5855577A (en) * 1996-09-17 1999-01-05 Eclipse Surgical Technologies, Inc. Bow shaped catheter
US5860974A (en) * 1993-07-01 1999-01-19 Boston Scientific Corporation Heart ablation catheter with expandable electrode and method of coupling energy to an electrode on a catheter shaft
US5863291A (en) * 1996-04-08 1999-01-26 Cardima, Inc. Linear ablation assembly
US5865791A (en) * 1995-06-07 1999-02-02 E.P. Technologies Inc. Atrial appendage stasis reduction procedure and devices
US5868740A (en) * 1995-03-24 1999-02-09 Board Of Regents-Univ Of Nebraska Method for volumetric tissue ablation
US5871443A (en) * 1992-09-25 1999-02-16 Ep Technologies, Inc. Cardiac mapping and ablation systems
US5871523A (en) * 1993-10-15 1999-02-16 Ep Technologies, Inc. Helically wound radio-frequency emitting electrodes for creating lesions in body tissue
US5873865A (en) * 1997-02-07 1999-02-23 Eclipse Surgical Technologies, Inc. Spiral catheter with multiple guide holes
US5876399A (en) * 1997-05-28 1999-03-02 Irvine Biomedical, Inc. Catheter system and methods thereof
US5876340A (en) * 1997-04-17 1999-03-02 Irvine Biomedical, Inc. Ablation apparatus with ultrasonic imaging capabilities
US5882346A (en) * 1996-07-15 1999-03-16 Cardiac Pathways Corporation Shapable catheter using exchangeable core and method of use
US5881727A (en) * 1993-10-14 1999-03-16 Ep Technologies, Inc. Integrated cardiac mapping and ablation probe
US6009877A (en) * 1994-06-24 2000-01-04 Edwards; Stuart D. Method for treating a sphincter
US6010500A (en) * 1997-07-21 2000-01-04 Cardiac Pathways Corporation Telescoping apparatus and method for linear lesion ablation
US6014579A (en) * 1997-07-21 2000-01-11 Cardiac Pathways Corp. Endocardial mapping catheter with movable electrode
US6016437A (en) * 1996-10-21 2000-01-18 Irvine Biomedical, Inc. Catheter probe system with inflatable soft shafts
US6023638A (en) * 1995-07-28 2000-02-08 Scimed Life Systems, Inc. System and method for conducting electrophysiological testing using high-voltage energy pulses to stun tissue
US6024740A (en) * 1997-07-08 2000-02-15 The Regents Of The University Of California Circumferential ablation device assembly
US6029091A (en) * 1998-07-09 2000-02-22 Irvine Biomedical, Inc. Catheter system having lattice electrodes
US6033397A (en) * 1996-03-05 2000-03-07 Vnus Medical Technologies, Inc. Method and apparatus for treating esophageal varices
US6036689A (en) * 1998-09-24 2000-03-14 Tu; Lily Chen Ablation device for treating atherosclerotic tissues
US6036687A (en) * 1996-03-05 2000-03-14 Vnus Medical Technologies, Inc. Method and apparatus for treating venous insufficiency
US6039731A (en) * 1995-06-09 2000-03-21 Engineering & Research Associates, Inc. Apparatus and method for determining the extent of ablation
US6179833B1 (en) * 1995-06-09 2001-01-30 Engineering & Research Associates, Inc. Apparatus for thermal ablation
US6183468B1 (en) * 1998-09-10 2001-02-06 Scimed Life Systems, Inc. Systems and methods for controlling power in an electrosurgical probe
US6197026B1 (en) * 1998-05-06 2001-03-06 Erbe Elektromedizin Gmbh Electrosurgical instrument
US6198970B1 (en) * 1995-10-27 2001-03-06 Esd Limited Liability Company Method and apparatus for treating oropharyngeal respiratory and oral motor neuromuscular disorders with electrical stimulation
US6200332B1 (en) * 1999-07-09 2001-03-13 Ceramoptec Industries, Inc. Device and method for underskin laser treatments
US6200333B1 (en) * 1997-04-07 2001-03-13 Broncus Technologies, Inc. Bronchial stenter
US6200311B1 (en) * 1998-01-20 2001-03-13 Eclipse Surgical Technologies, Inc. Minimally invasive TMR device
US6338727B1 (en) * 1998-08-13 2002-01-15 Alsius Corporation Indwelling heat exchange catheter and method of using same
US6338836B1 (en) * 1999-09-28 2002-01-15 Siemens Aktiengesellschaft Asthma analysis method employing hyperpolarized gas and magnetic resonance imaging
US6514246B1 (en) * 1993-10-14 2003-02-04 Ep Technologies, Inc. Systems and methods for forming large lesions in body tissue using curvilinear electrode elements
US6526320B2 (en) * 1998-11-16 2003-02-25 United States Surgical Corporation Apparatus for thermal treatment of tissue
US6529756B1 (en) * 1999-11-22 2003-03-04 Scimed Life Systems, Inc. Apparatus for mapping and coagulating soft tissue in or around body orifices
US20030050631A1 (en) * 2000-12-29 2003-03-13 Afx, Inc. Tissue ablation apparatus with a sliding ablation instrument and method
US20030233099A1 (en) * 2000-10-17 2003-12-18 Broncus Technologies, Inc. Modification of airways by application of energy
US6673068B1 (en) * 2000-04-12 2004-01-06 Afx, Inc. Electrode arrangement for use in a medical instrument
US6692492B2 (en) * 2001-11-28 2004-02-17 Cardiac Pacemaker, Inc. Dielectric-coated ablation electrode having a non-coated window with thermal sensors
US20040031494A1 (en) * 1998-06-10 2004-02-19 Broncus Technologies, Inc. Methods of treating asthma
US6699243B2 (en) * 2001-09-19 2004-03-02 Curon Medical, Inc. Devices, systems and methods for treating tissue regions of the body
US6714822B2 (en) * 1998-04-30 2004-03-30 Medtronic, Inc. Apparatus and method for expanding a stimulation lead body in situ
US20040176755A1 (en) * 2001-12-18 2004-09-09 Scimed Life Systems, Inc., A Minnesota Corporation Cryo-temperature monitoring
US6837888B2 (en) * 1995-06-07 2005-01-04 Arthrocare Corporation Electrosurgical probe with movable return electrode and methods related thereto
US6840243B2 (en) * 2000-03-04 2005-01-11 Emphasys Medical, Inc. Methods and devices for use in performing pulmonary procedures
US20050010138A1 (en) * 2003-07-11 2005-01-13 Mangiardi Eric K. Lumen-measuring devices and method
US20050010270A1 (en) * 1998-06-10 2005-01-13 Asthmatx, Inc. Method of treating airways in the lung
US20050015083A1 (en) * 1994-10-07 2005-01-20 Scimed Life Systems, Inc. Loop structures for positioning a diagnostic or therapeutic element on the epicardium or other organ surface
US6849073B2 (en) * 1998-07-07 2005-02-01 Medtronic, Inc. Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue
US6852110B2 (en) * 2002-08-01 2005-02-08 Solarant Medical, Inc. Needle deployment for temperature sensing from an electrode
US6852091B2 (en) * 1992-08-12 2005-02-08 Medtronic Vidamed, Inc. Medical probe device and method
US6866662B2 (en) * 2002-07-23 2005-03-15 Biosense Webster, Inc. Ablation catheter having stabilizing array
US6869437B1 (en) * 2000-11-13 2005-03-22 Cardica, Inc. Method and system for performing closed-chest bypass
US6872206B2 (en) * 1998-02-19 2005-03-29 Curon Medical, Inc. Methods for treating the cardia of the stomach
US20050070821A1 (en) * 2003-07-31 2005-03-31 Deal Stephen E. System and method for introducing a prosthesis
US20050149099A1 (en) * 2003-12-19 2005-07-07 Olympus Corporation Submucosal layer dissection instrument, submucosal layer dissection system, and submucosal layer dissection method
US20060062808A1 (en) * 2004-09-18 2006-03-23 Asthmatx, Inc. Inactivation of smooth muscle tissue
US20090018538A1 (en) * 2007-07-12 2009-01-15 Asthmatx, Inc. Systems and methods for delivering energy to passageways in a patient
US20090043301A1 (en) * 2007-08-09 2009-02-12 Asthmatx, Inc. Monopolar energy delivery devices and methods for controlling current density in tissue

Family Cites Families (278)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1155169A (en) 1914-11-28 1915-09-28 John Starkweather Surgical instrument.
US1207479A (en) 1915-03-05 1916-12-05 Holger Bisgaard Self-retaining gatheter.
US3320957A (en) 1964-05-21 1967-05-23 Sokolik Edward Surgical instrument
US3667476A (en) 1970-04-27 1972-06-06 Bio Data Corp Apparatus for monitoring body temperature and controlling a heating device to maintain a selected temperature
US3692029A (en) 1971-05-03 1972-09-19 Edwin Lloyd Adair Retention catheter and suprapubic shunt
JPS5394480A (en) * 1977-01-31 1978-08-18 Olympus Optical Co Method of forming index of long insertion
JPS57168656A (en) 1981-04-10 1982-10-18 Medos Kenkyusho Kk Endoscope laser coagulator
US4706688A (en) 1981-05-18 1987-11-17 Don Michael T Anthony Non-invasive cardiac device
US4612934A (en) 1981-06-30 1986-09-23 Borkan William N Non-invasive multiprogrammable tissue stimulator
US4584998A (en) 1981-09-11 1986-04-29 Mallinckrodt, Inc. Multi-purpose tracheal tube
US4462402A (en) * 1982-11-15 1984-07-31 Minnesota Mining And Manufacturing Company Method and anchor for anchoring
US4522212A (en) 1983-11-14 1985-06-11 Mansfield Scientific, Inc. Endocardial electrode
FR2561929B1 (en) 1984-03-27 1989-02-03 Atesys IMPLANTED AUTOMATIC APPARATUS FOR VENTRICULAR DEFIBRILLATION
JPS6148350A (en) 1984-08-15 1986-03-10 オリンパス光学工業株式会社 Medical laser apparatus
US5019075A (en) 1984-10-24 1991-05-28 The Beth Israel Hospital Method and apparatus for angioplasty
US4862886A (en) 1985-05-08 1989-09-05 Summit Technology Inc. Laser angioplasty
US4976709A (en) 1988-12-15 1990-12-11 Sand Bruce J Method for collagen treatment
US4827935A (en) 1986-04-24 1989-05-09 Purdue Research Foundation Demand electroventilator
US4709698A (en) 1986-05-14 1987-12-01 Thomas J. Fogarty Heatable dilation catheter
US5215103A (en) 1986-11-14 1993-06-01 Desai Jawahar M Catheter for mapping and ablation and method therefor
JPS6446056U (en) 1987-09-17 1989-03-22
US5588432A (en) 1988-03-21 1996-12-31 Boston Scientific Corporation Catheters for imaging, sensing electrical potentials, and ablating tissue
US5010892A (en) 1988-05-04 1991-04-30 Triangle Research And Development Corp. Body lumen measuring instrument
US4967765A (en) 1988-07-28 1990-11-06 Bsd Medical Corporation Urethral inserted applicator for prostate hyperthermia
US4920978A (en) 1988-08-31 1990-05-01 Triangle Research And Development Corporation Method and apparatus for the endoscopic treatment of deep tumors using RF hyperthermia
US4955377A (en) 1988-10-28 1990-09-11 Lennox Charles D Device and method for heating tissue in a patient's body
US4945912A (en) 1988-11-25 1990-08-07 Sensor Electronics, Inc. Catheter with radiofrequency heating applicator
US5779698A (en) 1989-01-18 1998-07-14 Applied Medical Resources Corporation Angioplasty catheter system and method for making same
US5433730A (en) 1989-05-03 1995-07-18 Intermedics, Inc. Conductive pouch electrode for defibrillation
US5152286A (en) 1989-05-08 1992-10-06 Mezhotraslevoi Nauchnoinzhenerny Tsentr "Vidguk" Method of microwave resonance therapy and device therefor
US5074860A (en) 1989-06-09 1991-12-24 Heraeus Lasersonics, Inc. Apparatus for directing 10.6 micron laser radiation to a tissue site
US5057105A (en) 1989-08-28 1991-10-15 The University Of Kansas Med Center Hot tip catheter assembly
US5117828A (en) 1989-09-25 1992-06-02 Arzco Medical Electronics, Inc. Expandable esophageal catheter
US5203832A (en) 1989-11-17 1993-04-20 Long Manufacturing Ltd. Circumferential flow heat exchanger
US5254088A (en) 1990-02-02 1993-10-19 Ep Technologies, Inc. Catheter steering mechanism
FR2659240B1 (en) 1990-03-06 1997-07-04 Daniel Galley EPIDURAL ELECTRODE SYSTEM CALLED TO BE INTRODUCED INTO THE EPIDURAL SPACE.
US5549559A (en) 1990-03-22 1996-08-27 Argomed Ltd. Thermal treatment apparatus
US5236413B1 (en) 1990-05-07 1996-06-18 Andrew J Feiring Method and apparatus for inducing the permeation of medication into internal tissue
US5265604A (en) 1990-05-14 1993-11-30 Vince Dennis J Demand - diaphragmatic pacing (skeletal muscle pressure modified)
US5056519A (en) 1990-05-14 1991-10-15 Vince Dennis J Unilateral diaphragmatic pacer
US5103804A (en) 1990-07-03 1992-04-14 Boston Scientific Corporation Expandable tip hemostatic probes and the like
US5135517A (en) 1990-07-19 1992-08-04 Catheter Research, Inc. Expandable tube-positioning apparatus
US5170803A (en) 1990-09-28 1992-12-15 Brunswick Biomedical Technologies, Inc. Esophageal displacement electrode
US5053033A (en) 1990-10-10 1991-10-01 Boston Advanced Technologies, Inc. Inhibition of restenosis by ultraviolet radiation
US5174288A (en) 1990-11-30 1992-12-29 Medtronic, Inc. Method and apparatus for cardiac defibrillation
US5324255A (en) 1991-01-11 1994-06-28 Baxter International Inc. Angioplasty and ablative devices having onboard ultrasound components and devices and methods for utilizing ultrasound to treat or prevent vasopasm
US5345936A (en) 1991-02-15 1994-09-13 Cardiac Pathways Corporation Apparatus with basket assembly for endocardial mapping
US5415166A (en) 1991-02-15 1995-05-16 Cardiac Pathways Corporation Endocardial mapping apparatus and cylindrical semiconductor device mounting structure for use therewith and method
US5465717A (en) 1991-02-15 1995-11-14 Cardiac Pathways Corporation Apparatus and Method for ventricular mapping and ablation
US5409453A (en) 1992-08-12 1995-04-25 Vidamed, Inc. Steerable medical probe with stylets
RU2091054C1 (en) 1991-03-25 1997-09-27 Владивостокский государственный медицинский университет Method for treating asthmatic bronchitis in children affected with constitutional diathesis
US5116864A (en) 1991-04-09 1992-05-26 Indiana University Foundation Method for preventing restenosis following reconfiguration of body vessels
JPH06507097A (en) 1991-04-10 1994-08-11 ビーティージー・インターナショナル・インコーポレーテッド Defibrillator, temporary pacer catheter, and its implantation method
US5255678A (en) 1991-06-21 1993-10-26 Ecole Polytechnique Mapping electrode balloon
JP3171628B2 (en) * 1991-12-26 2001-05-28 オリンパス光学工業株式会社 High frequency knife for endoscope
US6053172A (en) 1995-06-07 2000-04-25 Arthrocare Corporation Systems and methods for electrosurgical sinus surgery
US6159194A (en) 1992-01-07 2000-12-12 Arthrocare Corporation System and method for electrosurgical tissue contraction
US5366443A (en) 1992-01-07 1994-11-22 Thapliyal And Eggers Partners Method and apparatus for advancing catheters through occluded body lumens
US5509411A (en) 1993-01-29 1996-04-23 Cardima, Inc. Intravascular sensing device
US5699796A (en) 1993-01-29 1997-12-23 Cardima, Inc. High resolution intravascular signal detection
RU2053814C1 (en) 1992-02-11 1996-02-10 Новиков Валерий Николаевич Method for treatment of local endobronchitis
US5540681A (en) 1992-04-10 1996-07-30 Medtronic Cardiorhythm Method and system for radiofrequency ablation of tissue
US5269758A (en) 1992-04-29 1993-12-14 Taheri Syde A Intravascular catheter and method for treatment of hypothermia
US5443470A (en) 1992-05-01 1995-08-22 Vesta Medical, Inc. Method and apparatus for endometrial ablation
US5255679A (en) 1992-06-02 1993-10-26 Cardiac Pathways Corporation Endocardial catheter for mapping and/or ablation with an expandable basket structure having means for providing selective reinforcement and pressure sensing mechanism for use therewith, and method
US5324284A (en) 1992-06-05 1994-06-28 Cardiac Pathways, Inc. Endocardial mapping and ablation system utilizing a separately controlled ablation catheter and method
US5782239A (en) 1992-06-30 1998-07-21 Cordis Webster, Inc. Unique electrode configurations for cardiovascular electrode catheter with built-in deflection method and central puller wire
US5411025A (en) 1992-06-30 1995-05-02 Cordis Webster, Inc. Cardiovascular catheter with laterally stable basket-shaped electrode array
US5772590A (en) 1992-06-30 1998-06-30 Cordis Webster, Inc. Cardiovascular catheter with laterally stable basket-shaped electrode array with puller wire
US5630794A (en) 1992-08-12 1997-05-20 Vidamed, Inc. Catheter tip and method of manufacturing
GB9219102D0 (en) 1992-09-09 1992-10-21 Fairfax Andrew J Flowmeters
US5311866A (en) 1992-09-23 1994-05-17 Endocardial Therapeutics, Inc. Heart mapping catheter
US5313943A (en) 1992-09-25 1994-05-24 Ep Technologies, Inc. Catheters and methods for performing cardiac diagnosis and treatment
US6086581A (en) 1992-09-29 2000-07-11 Ep Technologies, Inc. Large surface cardiac ablation catheter that assumes a low profile during introduction into the heart
US5471982A (en) 1992-09-29 1995-12-05 Ep Technologies, Inc. Cardiac mapping and ablation systems
DE669839T1 (en) 1992-10-01 1996-10-10 Cardiac Pacemakers Inc STENT-LIKE STRUCTURE FOR DEFLICTION ELECTRODES.
US5431696A (en) 1992-10-13 1995-07-11 Atlee, Iii; John L. Esophageal probe for transeophageal cardiac stimulation
US5807306A (en) 1992-11-09 1998-09-15 Cortrak Medical, Inc. Polymer matrix drug delivery apparatus
US5545161A (en) 1992-12-01 1996-08-13 Cardiac Pathways Corporation Catheter for RF ablation having cooled electrode with electrically insulated sleeve
US5348554A (en) 1992-12-01 1994-09-20 Cardiac Pathways Corporation Catheter for RF ablation with cooled electrode
US5256141A (en) 1992-12-22 1993-10-26 Nelson Gencheff Biological material deployment method and apparatus
CA2158453C (en) 1993-03-16 1999-11-16 Thomas F. Kordis Multiple electrode support structures
WO1994021170A1 (en) 1993-03-16 1994-09-29 Ep Technologies, Inc. Flexible circuit assemblies employing ribbon cable
US5893847A (en) 1993-03-16 1999-04-13 Ep Technologies, Inc. Multiple electrode support structures with slotted hub and hoop spline elements
US5823189A (en) 1993-03-16 1998-10-20 Ep Technologies, Inc. Multiple electrode support structures with spline elements and over-molded hub
US5417687A (en) 1993-04-30 1995-05-23 Medical Scientific, Inc. Bipolar electrosurgical trocar
US6749604B1 (en) 1993-05-10 2004-06-15 Arthrocare Corporation Electrosurgical instrument with axially-spaced electrodes
US5456667A (en) 1993-05-20 1995-10-10 Advanced Cardiovascular Systems, Inc. Temporary stenting catheter with one-piece expandable segment
US5571088A (en) 1993-07-01 1996-11-05 Boston Scientific Corporation Ablation catheters
DE69432148T2 (en) 1993-07-01 2003-10-16 Boston Scient Ltd CATHETER FOR IMAGE DISPLAY, DISPLAY OF ELECTRICAL SIGNALS AND ABLATION
US5562619A (en) 1993-08-19 1996-10-08 Boston Scientific Corporation Deflectable catheter
US5464404A (en) 1993-09-20 1995-11-07 Abela Laser Systems, Inc. Cardiac ablation catheters and method
US5908446A (en) 1994-07-07 1999-06-01 Cardiac Pathways Corporation Catheter assembly, catheter and multi-port introducer for use therewith
US5626618A (en) 1993-09-24 1997-05-06 The Ohio State University Mechanical adjunct to cardiopulmonary resuscitation (CPR), and an electrical adjunct to defibrillation countershock, cardiac pacing, and cardiac monitoring
US5415656A (en) 1993-09-28 1995-05-16 American Medical Systems, Inc. Electrosurgical apparatus
WO1995010322A1 (en) 1993-10-15 1995-04-20 Ep Technologies, Inc. Creating complex lesion patterns in body tissue
US5991650A (en) 1993-10-15 1999-11-23 Ep Technologies, Inc. Surface coatings for catheters, direct contacting diagnostic and therapeutic devices
US5409469A (en) 1993-11-04 1995-04-25 Medtronic, Inc. Introducer system having kink resistant splittable sheath
US6071280A (en) 1993-11-08 2000-06-06 Rita Medical Systems, Inc. Multiple electrode ablation apparatus
US6641580B1 (en) 1993-11-08 2003-11-04 Rita Medical Systems, Inc. Infusion array ablation apparatus
US6438400B1 (en) 1993-12-06 2002-08-20 Heska Corporation Electrode for evaluating cardiac functions via esophagus
US5423812A (en) 1994-01-31 1995-06-13 Ellman; Alan G. Electrosurgical stripping electrode for palatopharynx tissue
US6216043B1 (en) 1994-03-04 2001-04-10 Ep Technologies, Inc. Asymmetric multiple electrode support structures
SE9401267D0 (en) 1994-04-14 1994-04-14 Siemens Elema Ab The electrode device
US5458596A (en) 1994-05-06 1995-10-17 Dorsal Orthopedic Corporation Method and apparatus for controlled contraction of soft tissue
US5547469A (en) 1994-05-13 1996-08-20 Boston Scientific Corporation Apparatus for performing diagnostic and therapeutic modalities in the biliary tree
US5478309A (en) 1994-05-27 1995-12-26 William P. Sweezer, Jr. Catheter system and method for providing cardiopulmonary bypass pump support during heart surgery
US5843077A (en) 1994-06-24 1998-12-01 Somnus Medical Technologies, Inc. Minimally invasive apparatus for internal ablation of turbinates with surface cooling
US6006755A (en) 1994-06-24 1999-12-28 Edwards; Stuart D. Method to detect and treat aberrant myoelectric activity
US5827277A (en) 1994-06-24 1998-10-27 Somnus Medical Technologies, Inc. Minimally invasive apparatus for internal ablation of turbinates
US5681308A (en) 1994-06-24 1997-10-28 Stuart D. Edwards Ablation apparatus for cardiac chambers
US6092528A (en) 1994-06-24 2000-07-25 Edwards; Stuart D. Method to treat esophageal sphincters
US5505730A (en) 1994-06-24 1996-04-09 Stuart D. Edwards Thin layer ablation apparatus
US6056744A (en) 1994-06-24 2000-05-02 Conway Stuart Medical, Inc. Sphincter treatment apparatus
US5680860A (en) 1994-07-07 1997-10-28 Cardiac Pathways Corporation Mapping and/or ablation catheter with coilable distal extremity and method for using same
US5623940A (en) 1994-08-02 1997-04-29 S.L.T. Japan Co., Ltd. Catheter apparatus with a sensor
US5454782A (en) 1994-08-11 1995-10-03 Perkins; Rodney C. Translumenal circumferential energy delivery device
US5549655A (en) 1994-09-21 1996-08-27 Medtronic, Inc. Method and apparatus for synchronized treatment of obstructive sleep apnea
US5522862A (en) 1994-09-21 1996-06-04 Medtronic, Inc. Method and apparatus for treating obstructive sleep apnea
US5836947A (en) 1994-10-07 1998-11-17 Ep Technologies, Inc. Flexible structures having movable splines for supporting electrode elements
US5885278A (en) 1994-10-07 1999-03-23 E.P. Technologies, Inc. Structures for deploying movable electrode elements
US6142994A (en) 1994-10-07 2000-11-07 Ep Technologies, Inc. Surgical method and apparatus for positioning a diagnostic a therapeutic element within the body
US5740808A (en) 1996-10-28 1998-04-21 Ep Technologies, Inc Systems and methods for guilding diagnostic or therapeutic devices in interior tissue regions
US5899882A (en) 1994-10-27 1999-05-04 Novoste Corporation Catheter apparatus for radiation treatment of a desired area in the vascular system of a patient
US5814029A (en) 1994-11-03 1998-09-29 Daig Corporation Guiding introducer system for use in ablation and mapping procedures in the left ventricle
US5711305A (en) 1995-02-17 1998-01-27 Ep Technologies, Inc. Systems and methods for acquiring endocardially or epicardially paced electrocardiograms
US5792064A (en) 1995-02-17 1998-08-11 Panescu; Dorin Systems and methods for analyzing cardiac biopotential morphologies by cross-correlation
ATE220307T1 (en) 1995-02-17 2002-07-15 Boston Scient Ltd ARRANGEMENT FOR SEQUENTIAL MEASURING BIOLOGICAL EVENTS
US5630425A (en) 1995-02-17 1997-05-20 Ep Technologies, Inc. Systems and methods for adaptive filtering artifacts from composite signals
CA2212808C (en) 1995-02-28 2007-12-04 Boston Scientific Corporation Polymeric implements for torque transmission
US5620438A (en) 1995-04-20 1997-04-15 Angiomedics Ii Incorporated Method and apparatus for treating vascular tissue following angioplasty to minimize restenosis
US5678535A (en) 1995-04-21 1997-10-21 Dimarco; Anthony Fortunato Method and apparatus for electrical stimulation of the respiratory muscles to achieve artificial ventilation in a patient
DK0782463T3 (en) 1995-04-28 2000-06-05 Target Therapeutics Inc High performance braided catheter
US5681280A (en) 1995-05-02 1997-10-28 Heart Rhythm Technologies, Inc. Catheter control system
US5755753A (en) 1995-05-05 1998-05-26 Thermage, Inc. Method for controlled contraction of collagen tissue
US6251104B1 (en) 1995-05-10 2001-06-26 Eclipse Surgical Technologies, Inc. Guiding catheter system for ablating heart tissue
US5782795A (en) 1995-06-30 1998-07-21 Xomed Surgical Products, Inc. Surgical suction cutting instrument with internal irrigation
WO1997004702A1 (en) 1995-07-28 1997-02-13 Ep Technologies, Inc. Systems and methods for conducting electrophysiological testing using high-voltage energy pulses to stun heart tissue
US5782827A (en) 1995-08-15 1998-07-21 Rita Medical Systems, Inc. Multiple antenna ablation apparatus and method with multiple sensor feedback
US5624439A (en) 1995-08-18 1997-04-29 Somnus Medical Technologies, Inc. Method and apparatus for treatment of air way obstructions
US6210367B1 (en) 1995-09-06 2001-04-03 Microwave Medical Systems, Inc. Intracorporeal microwave warming method and apparatus
US6496738B2 (en) 1995-09-06 2002-12-17 Kenneth L. Carr Dual frequency microwave heating apparatus
US5848972A (en) 1995-09-15 1998-12-15 Children's Medical Center Corporation Method for endocardial activation mapping using a multi-electrode catheter
US5833632A (en) 1995-12-07 1998-11-10 Sarcos, Inc. Hollow guide wire apparatus catheters
US5837001A (en) 1995-12-08 1998-11-17 C. R. Bard Radio frequency energy delivery system for multipolar electrode catheters
US5891136A (en) 1996-01-19 1999-04-06 Ep Technologies, Inc. Expandable-collapsible mesh electrode structures
US5846238A (en) 1996-01-19 1998-12-08 Ep Technologies, Inc. Expandable-collapsible electrode structures with distal end steering or manipulation
US5891135A (en) 1996-01-19 1999-04-06 Ep Technologies, Inc. Stem elements for securing tubing and electrical wires to expandable-collapsible electrode structures
US5904711A (en) 1996-02-08 1999-05-18 Heartport, Inc. Expandable thoracoscopic defibrillation catheter system and method
US6139527A (en) 1996-03-05 2000-10-31 Vnus Medical Technologies, Inc. Method and apparatus for treating hemorrhoids
US6152899A (en) 1996-03-05 2000-11-28 Vnus Medical Technologies, Inc. Expandable catheter having improved electrode design, and method for applying energy
US5755760A (en) 1996-03-11 1998-05-26 Medtronic, Inc. Deflectable catheter
US5699799A (en) 1996-03-26 1997-12-23 Siemens Corporate Research, Inc. Automatic determination of the curved axis of a 3-D tube-shaped object in image volume
US5979456A (en) 1996-04-22 1999-11-09 Magovern; George J. Apparatus and method for reversibly reshaping a body part
US5810807A (en) 1996-05-22 1998-09-22 Ganz; Robert A. Sphincterotome with deflectable cutting plane and method of using the same
US5824026A (en) 1996-06-12 1998-10-20 The Spectranetics Corporation Catheter for delivery of electric energy and a process for manufacturing same
US6743197B1 (en) 1996-07-10 2004-06-01 Novasys Medical, Inc. Treatment of discrete tissues in respiratory, urinary, circulatory, reproductive and digestive systems
US5810806A (en) * 1996-08-29 1998-09-22 Ethicon Endo-Surgery Methods and devices for collection of soft tissue
US5755716A (en) * 1996-08-30 1998-05-26 Garito; Jon C. Method for using an electrosurgical electrode for treating glaucoma
US5906636A (en) 1996-09-20 1999-05-25 Texas Heart Institute Heat treatment of inflamed tissue
KR100340252B1 (en) 1996-10-23 2002-06-12 사토 히로시 Method for manufacturing electrode for battery
US5904651A (en) 1996-10-28 1999-05-18 Ep Technologies, Inc. Systems and methods for visualizing tissue during diagnostic or therapeutic procedures
US5779669A (en) 1996-10-28 1998-07-14 C. R. Bard, Inc. Steerable catheter with fixed curve
US5752518A (en) 1996-10-28 1998-05-19 Ep Technologies, Inc. Systems and methods for visualizing interior regions of the body
US5848969A (en) 1996-10-28 1998-12-15 Ep Technologies, Inc. Systems and methods for visualizing interior tissue regions using expandable imaging structures
US5908445A (en) 1996-10-28 1999-06-01 Ep Technologies, Inc. Systems for visualizing interior tissue regions including an actuator to move imaging element
US5919147A (en) 1996-11-01 1999-07-06 Jain; Krishna M. Method and apparatus for measuring the vascular diameter of a vessel
US6073052A (en) 1996-11-15 2000-06-06 Zelickson; Brian D. Device and method for treatment of gastroesophageal reflux disease
US6071279A (en) 1996-12-19 2000-06-06 Ep Technologies, Inc. Branched structures for supporting multiple electrode elements
US5968087A (en) 1996-12-19 1999-10-19 Medtronic, Inc. Multi-component lead body for medical electrical leads
US6056769A (en) 1997-02-11 2000-05-02 Biointerventional Corporation Expansile device for use in blood vessels and tracts in the body and tension application device for use therewith and method
US5882329A (en) 1997-02-12 1999-03-16 Prolifix Medical, Inc. Apparatus and method for removing stenotic material from stents
US5999855A (en) 1997-02-28 1999-12-07 Dimarco; Anthony F. Method and apparatus for electrical activation of the expiratory muscles to restore cough
US5897554A (en) 1997-03-01 1999-04-27 Irvine Biomedical, Inc. Steerable catheter having a loop electrode
USH1905H (en) 1997-03-21 2000-10-03 Medtronic, Inc. Mechanism for adjusting the exposed surface area and position of an electrode along a lead body
US5954661A (en) 1997-03-31 1999-09-21 Thomas Jefferson University Tissue characterization and treatment using pacing
US6083255A (en) 1997-04-07 2000-07-04 Broncus Technologies, Inc. Bronchial stenter
US6273907B1 (en) 1997-04-07 2001-08-14 Broncus Technologies, Inc. Bronchial stenter
US7425212B1 (en) 1998-06-10 2008-09-16 Asthmatx, Inc. Devices for modification of airways by transfer of energy
US6283988B1 (en) 1997-04-07 2001-09-04 Broncus Technologies, Inc. Bronchial stenter having expandable electrodes
US7027869B2 (en) * 1998-01-07 2006-04-11 Asthmatx, Inc. Method for treating an asthma attack
US6488673B1 (en) 1997-04-07 2002-12-03 Broncus Technologies, Inc. Method of increasing gas exchange of a lung
US5972026A (en) 1997-04-07 1999-10-26 Broncus Technologies, Inc. Bronchial stenter having diametrically adjustable electrodes
US5971983A (en) 1997-05-09 1999-10-26 The Regents Of The University Of California Tissue ablation device and method of use
US6217576B1 (en) 1997-05-19 2001-04-17 Irvine Biomedical Inc. Catheter probe for treating focal atrial fibrillation in pulmonary veins
US6050992A (en) 1997-05-19 2000-04-18 Radiotherapeutics Corporation Apparatus and method for treating tissue with multiple electrodes
US5921999A (en) 1997-06-03 1999-07-13 Dileo; Frank System and method employing a pie-zoelectric crystal and transverse oscillation to perform a capsulotomy
US6251109B1 (en) 1997-06-27 2001-06-26 Daig Corporation Process and device for the treatment of atrial arrhythmia
US5824359A (en) 1997-06-30 1998-10-20 Becton Dickinson And Company Medical device lubricant containing lecithin
US6547788B1 (en) 1997-07-08 2003-04-15 Atrionx, Inc. Medical device with sensor cooperating with expandable member
US6500174B1 (en) 1997-07-08 2002-12-31 Atrionix, Inc. Circumferential ablation device assembly and methods of use and manufacture providing an ablative circumferential band along an expandable member
US6626903B2 (en) 1997-07-24 2003-09-30 Rex Medical, L.P. Surgical biopsy device
US5891138A (en) 1997-08-11 1999-04-06 Irvine Biomedical, Inc. Catheter system having parallel electrodes
US5916235A (en) 1997-08-13 1999-06-29 The Regents Of The University Of California Apparatus and method for the use of detachable coils in vascular aneurysms and body cavities
US5954717A (en) 1997-09-25 1999-09-21 Radiotherapeutics Corporation Method and system for heating solid tissue
US6045549A (en) 1997-09-30 2000-04-04 Somnus Medical Technologies, Inc. Tissue ablation apparatus and device for use therein and method
US6645200B1 (en) 1997-10-10 2003-11-11 Scimed Life Systems, Inc. Method and apparatus for positioning a diagnostic or therapeutic element within the body and tip electrode for use with same
US6071281A (en) 1998-05-05 2000-06-06 Ep Technologies, Inc. Surgical method and apparatus for positioning a diagnostic or therapeutic element within the body and remote power control unit for use with same
JPH11113924A (en) * 1997-10-13 1999-04-27 Olympus Optical Co Ltd High frequency knife for endoscope
US6917834B2 (en) 1997-12-03 2005-07-12 Boston Scientific Scimed, Inc. Devices and methods for creating lesions in endocardial and surrounding tissue to isolate focal arrhythmia substrates
US6258087B1 (en) * 1998-02-19 2001-07-10 Curon Medical, Inc. Expandable electrode assemblies for forming lesions to treat dysfunction in sphincters and adjoining tissue regions
US6142993A (en) 1998-02-27 2000-11-07 Ep Technologies, Inc. Collapsible spline structure using a balloon as an expanding actuator
JP2002505138A (en) 1998-03-06 2002-02-19 キューロン メディカル,インコーポレイテッド Instrument for electrosurgically treating the esophageal sphincter
JP2002506672A (en) 1998-03-19 2002-03-05 オーレイテック インターヴェンションズ インコーポレイテッド Catheter for delivering energy to the surgical site
US6003517A (en) 1998-04-30 1999-12-21 Ethicon Endo-Surgery, Inc. Method for using an electrosurgical device on lung tissue
US6045550A (en) 1998-05-05 2000-04-04 Cardiac Peacemakers, Inc. Electrode having non-joined thermocouple for providing multiple temperature-sensitive junctions
US6493589B1 (en) 1998-05-07 2002-12-10 Medtronic, Inc. Methods and apparatus for treatment of pulmonary conditions
US6241727B1 (en) 1998-05-27 2001-06-05 Irvine Biomedical, Inc. Ablation catheter system having circular lesion capabilities
US5997534A (en) 1998-06-08 1999-12-07 Tu; Hosheng Medical ablation device and methods thereof
US20070123958A1 (en) 1998-06-10 2007-05-31 Asthmatx, Inc. Apparatus for treating airways in the lung
US6119030A (en) 1998-06-22 2000-09-12 Ep Technologies, Inc. Silicone tip for multiple electrode basket assemblies
US6066132A (en) 1998-06-30 2000-05-23 Ethicon, Inc. Articulating endometrial ablation device
US6322559B1 (en) 1998-07-06 2001-11-27 Vnus Medical Technologies, Inc. Electrode catheter having coil structure
US6296639B1 (en) 1999-02-12 2001-10-02 Novacept Apparatuses and methods for interstitial tissue removal
US6129751A (en) 1998-07-28 2000-10-10 Intermedics Inc. Cardiac lead with active fixation and biocompatible lubricant
US6322584B2 (en) 1998-07-31 2001-11-27 Surx, Inc. Temperature sensing devices and methods to shrink tissues
US5992419A (en) 1998-08-20 1999-11-30 Mmtc, Inc. Method employing a tissue-heating balloon catheter to produce a "biological stent" in an orifice or vessel of a patient's body
US5980563A (en) 1998-08-31 1999-11-09 Tu; Lily Chen Ablation apparatus and methods for treating atherosclerosis
US6123703A (en) 1998-09-19 2000-09-26 Tu; Lily Chen Ablation catheter and methods for treating tissues
DE60024585T2 (en) * 1999-02-19 2006-08-03 Boston Scientific Ltd., St. Michael LASER APPARATUS FOR STONE COZY WITH SUCTION
US6582427B1 (en) 1999-03-05 2003-06-24 Gyrus Medical Limited Electrosurgery system
US6409723B1 (en) 1999-04-02 2002-06-25 Stuart D. Edwards Treating body tissue by applying energy and substances
US6325797B1 (en) 1999-04-05 2001-12-04 Medtronic, Inc. Ablation catheter and method for isolating a pulmonary vein
US6149647A (en) 1999-04-19 2000-11-21 Tu; Lily Chen Apparatus and methods for tissue treatment
US6270476B1 (en) 1999-04-23 2001-08-07 Cryocath Technologies, Inc. Catheter
WO2000074565A1 (en) 1999-06-05 2000-12-14 Wilson-Cook Medical Inc. Indicia for an endoscopic medical device
US6235024B1 (en) 1999-06-21 2001-05-22 Hosheng Tu Catheters system having dual ablation capability
US6364878B1 (en) 1999-07-07 2002-04-02 Cardiac Pacemakers, Inc. Percutaneous transluminal ablation catheter manipulation tool
US7175644B2 (en) * 2001-02-14 2007-02-13 Broncus Technologies, Inc. Devices and methods for maintaining collateral channels in tissue
US6749606B2 (en) 1999-08-05 2004-06-15 Thomas Keast Devices for creating collateral channels
US20040249401A1 (en) 1999-10-05 2004-12-09 Omnisonics Medical Technologies, Inc. Apparatus and method for an ultrasonic medical device with a non-compliant balloon
US6645199B1 (en) 1999-11-22 2003-11-11 Scimed Life Systems, Inc. Loop structures for supporting diagnostic and therapeutic elements contact with body tissue and expandable push devices for use with same
US6547776B1 (en) 2000-01-03 2003-04-15 Curon Medical, Inc. Systems and methods for treating tissue in the crura
US6589235B2 (en) 2000-01-21 2003-07-08 The Regents Of The University Of California Method and apparatus for cartilage reshaping by radiofrequency heating
US6723091B2 (en) 2000-02-22 2004-04-20 Gyrus Medical Limited Tissue resurfacing
US6544226B1 (en) 2000-03-13 2003-04-08 Curon Medical, Inc. Operative devices that can be removably fitted on catheter bodies to treat tissue regions in the body
US6770070B1 (en) * 2000-03-17 2004-08-03 Rita Medical Systems, Inc. Lung treatment apparatus and method
US20010031981A1 (en) 2000-03-31 2001-10-18 Evans Michael A. Method and device for locating guidewire and treating chronic total occlusions
US7497844B2 (en) 2000-03-31 2009-03-03 Medtronic, Inc. System and method for positioning implantable medical devices within coronary veins
US6640120B1 (en) 2000-10-05 2003-10-28 Scimed Life Systems, Inc. Probe assembly for mapping and ablating pulmonary vein tissue and method of using same
US7104987B2 (en) * 2000-10-17 2006-09-12 Asthmatx, Inc. Control system and process for application of energy to airway walls and other mediums
US6575623B2 (en) 2000-11-10 2003-06-10 Cardiostream, Inc. Guide wire having extendable contact sensors for measuring temperature of vessel walls
US6676657B2 (en) 2000-12-07 2004-01-13 The United States Of America As Represented By The Department Of Health And Human Services Endoluminal radiofrequency cauterization system
US20020072737A1 (en) 2000-12-08 2002-06-13 Medtronic, Inc. System and method for placing a medical electrical lead
US6743226B2 (en) 2001-02-09 2004-06-01 Cosman Company, Inc. Adjustable trans-urethral radio-frequency ablation
US6647281B2 (en) 2001-04-06 2003-11-11 Scimed Life Systems, Inc. Expandable diagnostic or therapeutic apparatus and system for introducing the same into the body
US6620159B2 (en) 2001-06-06 2003-09-16 Scimed Life Systems, Inc. Conductive expandable electrode body and method of manufacturing the same
US6606521B2 (en) 2001-07-09 2003-08-12 Neuropace, Inc. Implantable medical lead
US6802843B2 (en) 2001-09-13 2004-10-12 Csaba Truckai Electrosurgical working end with resistive gradient electrodes
US7615049B2 (en) 2001-09-19 2009-11-10 Mederi Therapeutics, Inc. Devices, systems and methods for treating tissue regions of the body
JP3607231B2 (en) 2001-09-28 2005-01-05 有限会社日本エレクテル High frequency heating balloon catheter
US6895267B2 (en) 2001-10-24 2005-05-17 Scimed Life Systems, Inc. Systems and methods for guiding and locating functional elements on medical devices positioned in a body
US6669693B2 (en) 2001-11-13 2003-12-30 Mayo Foundation For Medical Education And Research Tissue ablation device and methods of using
US20060205996A1 (en) 2001-11-20 2006-09-14 Solorant Medical, Inc. Incontinence treatment with urethral guide
US6893436B2 (en) 2002-01-03 2005-05-17 Afx, Inc. Ablation instrument having a flexible distal portion
US20030153905A1 (en) * 2002-01-25 2003-08-14 Edwards Stuart Denzil Selective ablation system
US6881213B2 (en) 2002-06-28 2005-04-19 Ethicon, Inc. Device and method to expand treatment array
US6858025B2 (en) * 2002-08-06 2005-02-22 Medically Advanced Designs, Llc Cryo-surgical apparatus and method of use
AU2003264354A1 (en) * 2002-08-30 2004-04-30 Olympus Corporation Medical treatment system, endoscope system, endoscope insert operation program, and endoscope device
US20040082947A1 (en) 2002-10-25 2004-04-29 The Regents Of The University Of Michigan Ablation catheters
US20040153056A1 (en) 2002-11-11 2004-08-05 Berchtold Holding Gmbh, A German Corporation Probe
US7186251B2 (en) 2003-03-27 2007-03-06 Cierra, Inc. Energy based devices and methods for treatment of patent foramen ovale
US7637934B2 (en) 2003-03-31 2009-12-29 Merit Medical Systems, Inc. Medical appliance optical delivery and deployment apparatus and method
US20050096644A1 (en) 2003-10-30 2005-05-05 Hall Jeffrey A. Energy delivery optimization for RF duty cycle for lesion creation
US9555223B2 (en) * 2004-03-23 2017-01-31 Medtronic Cryocath Lp Method and apparatus for inflating and deflating balloon catheters
US7803150B2 (en) * 2004-04-21 2010-09-28 Acclarent, Inc. Devices, systems and methods useable for treating sinusitis
JP2007536985A (en) * 2004-05-13 2007-12-20 オムニソニックス メディカル テクノロジーズ インコーポレイテッド Ultrasound medical device and method for treating urolithiasis
US20060089637A1 (en) 2004-10-14 2006-04-27 Werneth Randell L Ablation catheter
WO2006052940A2 (en) 2004-11-05 2006-05-18 Asthmatx, Inc. Medical device with procedure improvement features
US7949407B2 (en) 2004-11-05 2011-05-24 Asthmatx, Inc. Energy delivery devices and methods
US7200445B1 (en) 2005-10-21 2007-04-03 Asthmatx, Inc. Energy delivery devices and methods
US20070093802A1 (en) 2005-10-21 2007-04-26 Danek Christopher J Energy delivery devices and methods
CA2585150C (en) * 2004-11-12 2014-10-07 Asthmatx, Inc. Improved energy delivery devices and methods
US20060135953A1 (en) 2004-12-22 2006-06-22 Wlodzimierz Kania Tissue ablation system including guidewire with sensing element
US20060200121A1 (en) 2005-03-03 2006-09-07 Mowery Thomas M Navigable, multi-positional and variable tissue ablation apparatus and methods
EP1874211B1 (en) 2005-04-21 2017-05-31 Boston Scientific Scimed, Inc. Control devices for energy delivery
US20070287994A1 (en) * 2006-06-12 2007-12-13 Pankaj Amrit Patel Endoscopically Introducible Expandable Bipolar Probe
CA2703414A1 (en) * 2008-01-11 2009-07-16 Boston Scientific Scimed, Inc. Ablation devices and methods of use

Patent Citations (102)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2072346A (en) * 1934-10-04 1937-03-02 Ward R Smith Drainage tube
US3568659A (en) * 1968-09-24 1971-03-09 James N Karnegis Disposable percutaneous intracardiac pump and method of pumping blood
US4317458A (en) * 1979-04-26 1982-03-02 Kabushiki Kaisha Top Electrode apparatus for pacing
US4565200A (en) * 1980-09-24 1986-01-21 Cosman Eric R Universal lesion and recording electrode system
US4503855A (en) * 1981-12-31 1985-03-12 Harald Maslanka High frequency surgical snare electrode
US4567882A (en) * 1982-12-06 1986-02-04 Vanderbilt University Method for locating the illuminated tip of an endotracheal tube
US4799479A (en) * 1984-10-24 1989-01-24 The Beth Israel Hospital Association Method and apparatus for angioplasty
US4643186A (en) * 1985-10-30 1987-02-17 Rca Corporation Percutaneous transluminal microwave catheter angioplasty
US5500011A (en) * 1986-11-14 1996-03-19 Desai; Jawahar M. Catheter for mapping and ablation and method therefor
US4802492A (en) * 1987-03-11 1989-02-07 National Jewish Center For Immunology And Respiratory Medicine Method for determining respiratory function
US5496311A (en) * 1988-10-28 1996-03-05 Boston Scientific Corporation Physiologic low stress angioplasty
US5191883A (en) * 1988-10-28 1993-03-09 Prutech Research And Development Partnership Ii Device for heating tissue in a patient's body
US5084044A (en) * 1989-07-14 1992-01-28 Ciron Corporation Apparatus for endometrial ablation and method of using same
US5292331A (en) * 1989-08-24 1994-03-08 Applied Vascular Engineering, Inc. Endovascular support device
US5707352A (en) * 1989-08-28 1998-01-13 Alliance Pharmaceutical Corp. Pulmonary delivery of therapeutic agent
US5100388A (en) * 1989-09-15 1992-03-31 Interventional Thermodynamics, Inc. Method and device for thermal ablation of hollow body organs
US5096916A (en) * 1990-05-07 1992-03-17 Aegis Technology, Inc. Treatment of chronic obstructive pulmonary disease (copd) by inhalation of an imidazoline
US5078716A (en) * 1990-05-11 1992-01-07 Doll Larry F Electrosurgical apparatus for resecting abnormal protruding growth
US5188602A (en) * 1990-07-12 1993-02-23 Interventional Thermodynamics, Inc. Method and device for delivering heat to hollow body organs
US5100423A (en) * 1990-08-21 1992-03-31 Medical Engineering & Development Institute, Inc. Ablation catheter
US5496271A (en) * 1990-09-14 1996-03-05 American Medical Systems, Inc. Combined hyperthermia and dilation catheter
US5383917A (en) * 1991-07-05 1995-01-24 Jawahar M. Desai Device and method for multi-phase radio-frequency ablation
US5281218A (en) * 1992-06-05 1994-01-25 Cardiac Pathways Corporation Catheter having needle electrode for radiofrequency ablation
US6852091B2 (en) * 1992-08-12 2005-02-08 Medtronic Vidamed, Inc. Medical probe device and method
US5293869A (en) * 1992-09-25 1994-03-15 Ep Technologies, Inc. Cardiac probe with dynamic support for maintaining constant surface contact during heart systole and diastole
US5871443A (en) * 1992-09-25 1999-02-16 Ep Technologies, Inc. Cardiac mapping and ablation systems
US5720745A (en) * 1992-11-24 1998-02-24 Erbe Electromedizin Gmbh Electrosurgical unit and method for achieving coagulation of biological tissue
US5725525A (en) * 1993-03-16 1998-03-10 Ep Technologies, Inc. Multiple electrode support structures with integral hub and spline elements
US5860974A (en) * 1993-07-01 1999-01-19 Boston Scientific Corporation Heart ablation catheter with expandable electrode and method of coupling energy to an electrode on a catheter shaft
US5396887A (en) * 1993-09-23 1995-03-14 Cardiac Pathways Corporation Apparatus and method for detecting contact pressure
US5607462A (en) * 1993-09-24 1997-03-04 Cardiac Pathways Corporation Catheter assembly, catheter and multi-catheter introducer for use therewith
US5730128A (en) * 1993-10-12 1998-03-24 Cardiac Pathways Corporation Endocardial mapping apparatus
US5400783A (en) * 1993-10-12 1995-03-28 Cardiac Pathways Corporation Endocardial mapping apparatus with rotatable arm and method
US5881727A (en) * 1993-10-14 1999-03-16 Ep Technologies, Inc. Integrated cardiac mapping and ablation probe
US6514246B1 (en) * 1993-10-14 2003-02-04 Ep Technologies, Inc. Systems and methods for forming large lesions in body tissue using curvilinear electrode elements
US5871523A (en) * 1993-10-15 1999-02-16 Ep Technologies, Inc. Helically wound radio-frequency emitting electrodes for creating lesions in body tissue
US5599345A (en) * 1993-11-08 1997-02-04 Zomed International, Inc. RF treatment apparatus
US5394880A (en) * 1994-03-17 1995-03-07 Atlee, Iii; John L. Esophageal stethoscope
US5598848A (en) * 1994-03-31 1997-02-04 Ep Technologies, Inc. Systems and methods for positioning multiple electrode structures in electrical contact with the myocardium
US6009877A (en) * 1994-06-24 2000-01-04 Edwards; Stuart D. Method for treating a sphincter
US20050015083A1 (en) * 1994-10-07 2005-01-20 Scimed Life Systems, Inc. Loop structures for positioning a diagnostic or therapeutic element on the epicardium or other organ surface
US5722401A (en) * 1994-10-19 1998-03-03 Cardiac Pathways Corporation Endocardial mapping and/or ablation catheter probe
US5601088A (en) * 1995-02-17 1997-02-11 Ep Technologies, Inc. Systems and methods for filtering artifacts from composite signals
US5595183A (en) * 1995-02-17 1997-01-21 Ep Technologies, Inc. Systems and methods for examining heart tissue employing multiple electrode structures and roving electrodes
US5605157A (en) * 1995-02-17 1997-02-25 Ep Technologies, Inc. Systems and methods for filtering signals derived from biological events
US5722416A (en) * 1995-02-17 1998-03-03 Ep Technologies, Inc. Systems and methods for analyzing biopotential morphologies in heart tissue to locate potential ablation sites
US5868740A (en) * 1995-03-24 1999-02-09 Board Of Regents-Univ Of Nebraska Method for volumetric tissue ablation
US5607419A (en) * 1995-04-24 1997-03-04 Angiomedics Ii Inc. Method and apparatus for treating vessel wall with UV radiation following angioplasty
US5865791A (en) * 1995-06-07 1999-02-02 E.P. Technologies Inc. Atrial appendage stasis reduction procedure and devices
US6837888B2 (en) * 1995-06-07 2005-01-04 Arthrocare Corporation Electrosurgical probe with movable return electrode and methods related thereto
US6039731A (en) * 1995-06-09 2000-03-21 Engineering & Research Associates, Inc. Apparatus and method for determining the extent of ablation
US6179833B1 (en) * 1995-06-09 2001-01-30 Engineering & Research Associates, Inc. Apparatus for thermal ablation
US6023638A (en) * 1995-07-28 2000-02-08 Scimed Life Systems, Inc. System and method for conducting electrophysiological testing using high-voltage energy pulses to stun tissue
US6198970B1 (en) * 1995-10-27 2001-03-06 Esd Limited Liability Company Method and apparatus for treating oropharyngeal respiratory and oral motor neuromuscular disorders with electrical stimulation
US5728094A (en) * 1996-02-23 1998-03-17 Somnus Medical Technologies, Inc. Method and apparatus for treatment of air way obstructions
US5730726A (en) * 1996-03-04 1998-03-24 Klingenstein; Ralph James Apparatus and method for removing fecal impaction
US6033397A (en) * 1996-03-05 2000-03-07 Vnus Medical Technologies, Inc. Method and apparatus for treating esophageal varices
US6036687A (en) * 1996-03-05 2000-03-14 Vnus Medical Technologies, Inc. Method and apparatus for treating venous insufficiency
US5863291A (en) * 1996-04-08 1999-01-26 Cardima, Inc. Linear ablation assembly
US5882346A (en) * 1996-07-15 1999-03-16 Cardiac Pathways Corporation Shapable catheter using exchangeable core and method of use
US5855577A (en) * 1996-09-17 1999-01-05 Eclipse Surgical Technologies, Inc. Bow shaped catheter
US6016437A (en) * 1996-10-21 2000-01-18 Irvine Biomedical, Inc. Catheter probe system with inflatable soft shafts
US5722403A (en) * 1996-10-28 1998-03-03 Ep Technologies, Inc. Systems and methods using a porous electrode for ablating and visualizing interior tissue regions
US5873865A (en) * 1997-02-07 1999-02-23 Eclipse Surgical Technologies, Inc. Spiral catheter with multiple guide holes
US5730741A (en) * 1997-02-07 1998-03-24 Eclipse Surgical Technologies, Inc. Guided spiral catheter
US6200333B1 (en) * 1997-04-07 2001-03-13 Broncus Technologies, Inc. Bronchial stenter
US5876340A (en) * 1997-04-17 1999-03-02 Irvine Biomedical, Inc. Ablation apparatus with ultrasonic imaging capabilities
US5876399A (en) * 1997-05-28 1999-03-02 Irvine Biomedical, Inc. Catheter system and methods thereof
US6024740A (en) * 1997-07-08 2000-02-15 The Regents Of The University Of California Circumferential ablation device assembly
US6014579A (en) * 1997-07-21 2000-01-11 Cardiac Pathways Corp. Endocardial mapping catheter with movable electrode
US6010500A (en) * 1997-07-21 2000-01-04 Cardiac Pathways Corporation Telescoping apparatus and method for linear lesion ablation
US6200311B1 (en) * 1998-01-20 2001-03-13 Eclipse Surgical Technologies, Inc. Minimally invasive TMR device
US6872206B2 (en) * 1998-02-19 2005-03-29 Curon Medical, Inc. Methods for treating the cardia of the stomach
US6714822B2 (en) * 1998-04-30 2004-03-30 Medtronic, Inc. Apparatus and method for expanding a stimulation lead body in situ
US6197026B1 (en) * 1998-05-06 2001-03-06 Erbe Elektromedizin Gmbh Electrosurgical instrument
US20040031494A1 (en) * 1998-06-10 2004-02-19 Broncus Technologies, Inc. Methods of treating asthma
US20050010270A1 (en) * 1998-06-10 2005-01-13 Asthmatx, Inc. Method of treating airways in the lung
US6849073B2 (en) * 1998-07-07 2005-02-01 Medtronic, Inc. Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue
US6029091A (en) * 1998-07-09 2000-02-22 Irvine Biomedical, Inc. Catheter system having lattice electrodes
US6338727B1 (en) * 1998-08-13 2002-01-15 Alsius Corporation Indwelling heat exchange catheter and method of using same
US6183468B1 (en) * 1998-09-10 2001-02-06 Scimed Life Systems, Inc. Systems and methods for controlling power in an electrosurgical probe
US6036689A (en) * 1998-09-24 2000-03-14 Tu; Lily Chen Ablation device for treating atherosclerotic tissues
US6526320B2 (en) * 1998-11-16 2003-02-25 United States Surgical Corporation Apparatus for thermal treatment of tissue
US6200332B1 (en) * 1999-07-09 2001-03-13 Ceramoptec Industries, Inc. Device and method for underskin laser treatments
US6338836B1 (en) * 1999-09-28 2002-01-15 Siemens Aktiengesellschaft Asthma analysis method employing hyperpolarized gas and magnetic resonance imaging
US6529756B1 (en) * 1999-11-22 2003-03-04 Scimed Life Systems, Inc. Apparatus for mapping and coagulating soft tissue in or around body orifices
US6840243B2 (en) * 2000-03-04 2005-01-11 Emphasys Medical, Inc. Methods and devices for use in performing pulmonary procedures
US6673068B1 (en) * 2000-04-12 2004-01-06 Afx, Inc. Electrode arrangement for use in a medical instrument
US20030233099A1 (en) * 2000-10-17 2003-12-18 Broncus Technologies, Inc. Modification of airways by application of energy
US6869437B1 (en) * 2000-11-13 2005-03-22 Cardica, Inc. Method and system for performing closed-chest bypass
US20030050631A1 (en) * 2000-12-29 2003-03-13 Afx, Inc. Tissue ablation apparatus with a sliding ablation instrument and method
US6699243B2 (en) * 2001-09-19 2004-03-02 Curon Medical, Inc. Devices, systems and methods for treating tissue regions of the body
US6692492B2 (en) * 2001-11-28 2004-02-17 Cardiac Pacemaker, Inc. Dielectric-coated ablation electrode having a non-coated window with thermal sensors
US20040176755A1 (en) * 2001-12-18 2004-09-09 Scimed Life Systems, Inc., A Minnesota Corporation Cryo-temperature monitoring
US6866662B2 (en) * 2002-07-23 2005-03-15 Biosense Webster, Inc. Ablation catheter having stabilizing array
US6852110B2 (en) * 2002-08-01 2005-02-08 Solarant Medical, Inc. Needle deployment for temperature sensing from an electrode
US20050010138A1 (en) * 2003-07-11 2005-01-13 Mangiardi Eric K. Lumen-measuring devices and method
US20050070821A1 (en) * 2003-07-31 2005-03-31 Deal Stephen E. System and method for introducing a prosthesis
US20050149099A1 (en) * 2003-12-19 2005-07-07 Olympus Corporation Submucosal layer dissection instrument, submucosal layer dissection system, and submucosal layer dissection method
US20060062808A1 (en) * 2004-09-18 2006-03-23 Asthmatx, Inc. Inactivation of smooth muscle tissue
US20090018538A1 (en) * 2007-07-12 2009-01-15 Asthmatx, Inc. Systems and methods for delivering energy to passageways in a patient
US20090043301A1 (en) * 2007-08-09 2009-02-12 Asthmatx, Inc. Monopolar energy delivery devices and methods for controlling current density in tissue

Cited By (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060225742A1 (en) * 2003-05-13 2006-10-12 The Foundry, Inc. Apparatus for treating asthma using neurotoxin
US10953170B2 (en) 2003-05-13 2021-03-23 Nuvaira, Inc. Apparatus for treating asthma using neurotoxin
US9339618B2 (en) 2003-05-13 2016-05-17 Holaira, Inc. Method and apparatus for controlling narrowing of at least one airway
US8489192B1 (en) 2008-02-15 2013-07-16 Holaira, Inc. System and method for bronchial dilation
US8731672B2 (en) 2008-02-15 2014-05-20 Holaira, Inc. System and method for bronchial dilation
US9125643B2 (en) 2008-02-15 2015-09-08 Holaira, Inc. System and method for bronchial dilation
US8483831B1 (en) 2008-02-15 2013-07-09 Holaira, Inc. System and method for bronchial dilation
US11058879B2 (en) 2008-02-15 2021-07-13 Nuvaira, Inc. System and method for bronchial dilation
US9668809B2 (en) 2008-05-09 2017-06-06 Holaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US10149714B2 (en) 2008-05-09 2018-12-11 Nuvaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8808280B2 (en) 2008-05-09 2014-08-19 Holaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8821489B2 (en) 2008-05-09 2014-09-02 Holaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8961507B2 (en) 2008-05-09 2015-02-24 Holaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8961508B2 (en) 2008-05-09 2015-02-24 Holaira, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8226638B2 (en) 2008-05-09 2012-07-24 Innovative Pulmonary Solutions, Inc. Systems, assemblies, and methods for treating a bronchial tree
US8740895B2 (en) 2009-10-27 2014-06-03 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US9017324B2 (en) 2009-10-27 2015-04-28 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US9005195B2 (en) 2009-10-27 2015-04-14 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US8932289B2 (en) 2009-10-27 2015-01-13 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US8777943B2 (en) 2009-10-27 2014-07-15 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US9931162B2 (en) 2009-10-27 2018-04-03 Nuvaira, Inc. Delivery devices with coolable energy emitting assemblies
US9649153B2 (en) 2009-10-27 2017-05-16 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US9675412B2 (en) 2009-10-27 2017-06-13 Holaira, Inc. Delivery devices with coolable energy emitting assemblies
US8911439B2 (en) 2009-11-11 2014-12-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
US9649154B2 (en) 2009-11-11 2017-05-16 Holaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
US11712283B2 (en) 2009-11-11 2023-08-01 Nuvaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
US10610283B2 (en) 2009-11-11 2020-04-07 Nuvaira, Inc. Non-invasive and minimally invasive denervation methods and systems for performing the same
US11389233B2 (en) 2009-11-11 2022-07-19 Nuvaira, Inc. Systems, apparatuses, and methods for treating tissue and controlling stenosis
US9149328B2 (en) 2009-11-11 2015-10-06 Holaira, Inc. Systems, apparatuses, and methods for treating tissue and controlling stenosis
US9398933B2 (en) 2012-12-27 2016-07-26 Holaira, Inc. Methods for improving drug efficacy including a combination of drug administration and nerve modulation
EP2959855A1 (en) * 2014-06-25 2015-12-30 Günter Farin Electrosurgical resection loop with an exposed part and with a part provided with an insulation
US11369433B2 (en) 2016-06-27 2022-06-28 Galvanize Therapeutics, Inc. Methods, apparatuses, and systems for the treatment of pulmonary disorders
US10702337B2 (en) 2016-06-27 2020-07-07 Galary, Inc. Methods, apparatuses, and systems for the treatment of pulmonary disorders
US10939958B2 (en) 2016-06-27 2021-03-09 Galary, Inc. Methods, apparatuses, and systems for the treatment of pulmonary disorders
US10328255B2 (en) 2016-09-16 2019-06-25 Precision Neurotechnologies Llc Visual prosthesis employing virtual neural electrode arrays
US10918857B2 (en) 2016-09-16 2021-02-16 Precision Neuroscience LLC Conformal electrode arrays for electrophysiologic recording and neural stimulation within the cerebral ventricles
US11406814B2 (en) 2016-09-16 2022-08-09 Precision Neuroscience Corporation Visual prosthesis employing ventricular or endovascular neural electrode arrays
US9867978B1 (en) 2016-09-16 2018-01-16 Precision Neurotechnologies Llc Conformal electrode arrays for electrophysiologic recording and neural stimulation within the cerebral ventricles

Also Published As

Publication number Publication date
AU2007309319A1 (en) 2008-05-02
CA2667009C (en) 2016-10-04
AU2007309319B2 (en) 2013-01-24
JP2010506677A (en) 2010-03-04
ES2398980T3 (en) 2013-03-25
EP2083734A4 (en) 2011-06-08
EP2083734B1 (en) 2012-12-12
CA2667009A1 (en) 2008-05-02
JP5422389B2 (en) 2014-02-19
EP2083734A2 (en) 2009-08-05
US20080097424A1 (en) 2008-04-24
US7931647B2 (en) 2011-04-26
WO2008051706A2 (en) 2008-05-02
WO2008051706A3 (en) 2008-06-26
US20150105775A1 (en) 2015-04-16

Similar Documents

Publication Publication Date Title
US7931647B2 (en) Method of delivering energy to a lung airway using markers
US11457974B2 (en) Catheter having flexible tip with multiple flexible segments
JP6165101B2 (en) Microwave energy delivery device and system
JP6437728B2 (en) Microwave energy delivery device and system
JP5836964B2 (en) Method and system for spinal radiofrequency nerve cutting
EP3804647A1 (en) Control methods and devices for energy delivery
US20120053485A1 (en) Catheter Having Needle And Expandable Support Member And Methods Of Use
BR112015002311B1 (en) Electrical ablation device and method of treating tissue electrosurgically
CN106413609A (en) Bladder tissue modification for overactive bladder disorders
US20230071306A1 (en) Systems and methods for delivering targeted therapy
CN109464187B (en) Device and method for treating lung tumors
EP1768591B1 (en) Flexible endoscope for endo luminal access radio frequency tumor ablation
US20220313353A1 (en) Ent instrument with rf electrodes on wire frame
US20220361944A1 (en) Energy Delivery System, Method and Device

Legal Events

Date Code Title Description
AS Assignment

Owner name: ASTHMATX, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WIZEMAN, WILLIAM J.;DALBEC, TIMOTHY R.;WEBSTER, NOAH;SIGNING DATES FROM 20061020 TO 20061027;REEL/FRAME:025985/0783

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION